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Background: In recent years, time-restricted feeding, alternate day fasting, and the Daniel Fast 
have garnered attention as potential dietary interventions to combat obesity. Objective: To 
compare the effects of various dietary models on measures of body composition and physical 
performance in male C57BL/6 mice. Methods: 60 young C57BL/6 male mice were assigned a diet 
of time-restricted feeding, alternate day fasting, the Daniel Fast, caloric restriction, a high-fat 
rodent diet, or a standard rodent chow for 8 weeks. Body composition and run time to exhaustion 
were determined. Results: Compared to the high-fat ad libitum group, all groups displayed 
significantly less weight and fat mass gain and non-significant changes in fat-free mass. 
Additionally, although not statistically significant, all groups displayed greater run time to 
exhaustion, relative to the high-fat ad libitum group. Conclusion: The Daniel Fast, time-restricted 
feeding, and alternate day fasting may improve body composition and physical performance as 
compared to a high-fat diet. 
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The prevalence of obesity - a complex condition caused by a combination of genetic, 
metabolic, social, behavioral, and cultural factors - has risen substantially in the United States since 
the year 1976 (1). Recent estimates indicate 36.5% of adult Americans are classified as obese, 
defined as a body mass index [BMI] of ≥ 30 kg∙m-2) (2). This figure is important because obesity 
is associated with negative alterations to many markers of overall health, notably with unfavorable 
changes in body composition (i.e. increased fat mass [FM], abdominal FM, and ratio of FM to fat-
free mass [FFM]) (1) and decreased physical fitness (3). Given that the prevalence of obesity is 
expected to increase in the coming decades, it is clear that novel interventions are needed to induce 
favorable changes in body composition and increases in physical fitness in obese individuals. 
In recent years, three dietary modifications have been suggested as potential aids in 
preventing and treating obesity: time-restricted feeding (TRF), alternate day fasting (ADF), and 
the Daniel fast (DF). TRF regimes restrict daily feeding periods to designated hours of the day (i.e. 
only eating from 12:00 pm – 7:00 pm), extending the typical overnight fast by several hours. 
Recent studies have indicated that TRF is capable of producing positive alterations in markers of 
overall health in humans, including positively altering blood lipids (4, 5), blood glucose (5), and 
blood insulin (5). With regard to body composition, studies in both humans (4, 5) and animals (6-
8) have suggested that TRF may be successful in inducing significant reductions in body mass and 
FM, while human studies have indicated that FFM can be maintained during this weight loss (4, 
5). Few studies have reported measures of physical fitness following a TRF intervention. Studies 
in humans have indicated that physical fitness levels are maintained in normal weight individuals 




C57BL/6J mice and one using Drosophila) have reported greater physical performance in TRF 
groups, relative to control groups (10, 11).  
Traditional ADF protocols follow the practice of fasting for one day, followed by ad 
libitum consumption on the subsequent day. Recent research has also utilized a modified ADF, 
which permits the consumption of small meals on fast days, typically consisting of 25-30% of 
normal daily caloric consumption (12, 13). Studies suggest that ADF may improve measures of 
cardio-metabolic health in humans, including decreased cholesterol (14-16), decreased LDL levels 
(14-16), decreased triglyceride levels (14-16), and decreased blood pressure (14, 17, 18). 
Additionally, ADF has been shown to improve measures of body composition in humans, resulting 
in significant reductions in FM (13-15, 17, 19, 20), visceral FM (20), and waist circumference (17, 
18) while maintaining FFM (13, 14, 17). To the author’s knowledge, no studies have reported 
measuring physical fitness following ADF.  
 The DF is a religious motivated fast derived from the Biblical book of Daniel (21). 
Typically, individuals partake in the DF for a 21-day period. It is a strict vegan diet that generally 
leads to reduced caloric intake. Individuals participating in a DF may consume fruits, vegetables, 
whole grains, nuts, legumes, seeds, and healthy oils (such as olive oil) ad libitum. Products that 
contain additives or preservatives, as well as caffeine and alcohol, are prohibited. In humans, the 
DF has resulted in improvements of many markers of overall health, including blood lipids, blood 
pressure, insulin, inflammation, and oxidative stress (21-24). With regards to body composition, 
only one study has indicated that DF results in significant alterations in body composition in 
humans (23). In this study, body mass, FM, and FFM all decreased significantly. However, other 
DF studies have failed to produce significant alterations in body composition, likely the result of 




typically 5-6 pounds over the course of a 21-day period. No DF studies have examined physical 
fitness in humans. However, one study in Long-Evans rats resulted in a significant increase in 
exercise capacity (run time to exhaustion) in mice consuming a DF-inspired chow and participating 
in regular exercise, relative to control groups (25). This indicates that the DF may result in 
increased physical fitness in rodent models.  
 Currently, no studies have compared these above dietary interventions within one protocol 
with respect to body composition and physical fitness. The proposed study aimed to accomplish 
this goal for the first time using a mouse model.   
Methods 
Mice and Dietary Protocol 
 Male C57BL/6 mice were used for this study, with 60 mice (7 groups of 8 mice, with 4 
additional mice obtained to ensure statistical power was maintained in the event of the death of an 
animal) allocated to one of seven groups. Mice were obtained at 4 weeks of age and were co-
housed (as described in Hatori, 2012) at the animal facility on the University of Memphis campus. 
They were entrained under a 12h light: 12h dark schedule for 2 weeks with standard rodent chow 
available ad libitum. During the 2-week entrainment period, mice began the reverse light-dark 
schedule, with lights off between the hours of 7am-7pm. This was done so that the feeding time 
was during the active phase (“lights off” phase) of the mice. Mice were housed in Life Sciences in 
an area that is used for studies of the circadian rhythm, and therefore, the light was well-regulated.  
Following the 2-week entrainment period, all mice entered a 6-week lead-in phase. During 
this 6-week lead-in period, 8 mice continued consuming a standard chow diet. These mice served 
as the control group (referred to as CHOW). They maintained ad libitum consumption of standard 




of 45% lard and 41% carbohydrate (20% sucrose, 9% corn starch, and 12% Maltodextrin). This 6-
week period of ad libitum feeding of a high-fat diet allowed for significant weight gain. Following 
the 6-week period lead-in period, the 52 mice fed the high-fat diet were divided into 6 additional 
groups (see Tables 1-3 for dietary composition of each diet):  
Group 1 (HF) had access to the high-fat diet ad libitum, 24 hours per day (n=8).  
Group 2 (SWITCH) had access to a standard rodent chow ad libitum, 24 hours per day (n=8). 
Group 3 (DF) had access to a purified, high-fiber, vegan-based diet ad libitum, 24 hours per day 
(n=10; 2 additional animals were assigned to this group following the death of 2 animals during 
baseline testing). The DF chow consumed by Group 3 (product: D13092801) was custom-made 
by Research Diets, Inc., based on the average macronutrient sources and quantities of the dietary 
intakes of human participants following the Daniel Fast in our previous studies (25).  
 Group 4 (CR) received 80% of ad libitum intake as determined during week 6 of the high-fat diet 
intake period (n=8).  
Group 5 (TRF) had ad libitum access to the high-fat diet for 6 hours at the beginning of their active 
phase (8am-2pm) (n=9; an additional animal was assigned to this group a priori because it was 
deemed a high-risk group).  
Group 6 (ADF) had ad libitum access to the Western diet every other day (n=9; an additional 
animal was assigned to this group a priori because it was deemed a high-risk group). That is, on 
day 1 they received as much food as desired during the entire 24-hour period. On day 2, they 
received no food. On day 3, they received ad libitum access to food, and so on.  
The diets were purchased from Research Diets, Inc (New Brunswick, NJ), which has 
experience in producing the high-fat diet and purified vegan diets for rodent studies. The mice 




diets until all testing was completed (~ middle of week 9). Water was provided ad libitum 
throughout the study period. The amount of food consumed was measured daily and the weights 
of the mice were taken on alternating days. Following the conclusion of post-testing, mice were 
euthanized with cervical dislocation (using isoflurane inhalation for anesthesia). 
Measurements of Body Composition 
Animals underwent a MRI for determination of body mass/body fat. This was done during 
the 6th week of the lead-in period (baseline) and 9th intervention week (post-intervention) using a 
small animal MRI unit (EchoMRI™) which uses a specialized NMR-MRI-based technology to 
rapidly measure lean and fatty tissue in small animals. Baseline and post-intervention scans were 
performed on the same days for all animals during the last hour of the animal’s inactive (light) 
phase. With regard to the ADF group, baseline and post-intervention scans were performed 
following 24 hours of feeding.  The total scan time for each animal was approximately 60 seconds. 
Animals simply remained in a stationary tubing while the scan was performed. There was no need 
to anesthetize the animals during the scan.  
Measurements of Physical Fitness 
Animals underwent a treadmill run-time-to-exhaustion test using a motorized treadmill 
with 5% incline. Animals ran at 20m/min for 30 min and 25m/min for the remaining time until 
they reach exhaustion. A warm-up was provided for 15min (5min at 5m/min, 5min at 10m/min, 
5min at 15m/min). Exhaustion was defined as the time at which mice were no longer able to 
continue running and sat on the shock grid with all 4 paws on the grid for 5 seconds, despite gentle 
hand prodding. The very mild electric shock was only used when mice did not respond well to 




point. The frequency and amplitude of shock was as low as possible (3Hz) to motivate the animals 
to remain on the treadmill belt, without causing unnecessary distress.  
The run-time-to-exhaustion testing was conducted twice in the mice, once prior to starting 
the intervention period (during the 6th week of the lead-in period) and once at the end of the 8th 
intervention week. The first run-time-to-exhaustion test was used to acclimate the mice to the 
treadmill and the run-time-to-exhaustion protocol. The second test was used as a primary 
dependent variable to characterize the aerobic capacity of each group after the 8-week intervention. 
Statistical Analysis 
 Data collected for anthropometric variables and the run-time-to-exhaustion test were 
analyzed using GraphPad Prism (GraphPad, LaJolla, CA, USA). A one-way ANOVA was used to 
calculate main effects, and Tukey post-hoc tests were used for multiple comparisons. An alpha 
value of 0.05 was used for all statistical testing. Cohen’s d was calculated for the run time to 
exhaustion data using Microsoft Excel (Microsoft, Redmond, WA, USA) to further explore the 
differences observed between the HF group and the DF, TRF, and ADF groups.  
Results 
Overview 
 Three animals died during the course of the study. One animal died during the 6th week of 
the lead-in period due to sepsis caused by an injury of unknown origin sustained to the left hind 
limb. Two animals (1 from the CHOW group and 1 from the DF group) died during the 6th week 
of the lead-in period while performing the run-time-to-exhaustion test. Both mice died instantly 
from injuries sustained as a result of falling between the shock grid and the treadmill belt. All 





Caloric Consumption Data 
 Caloric consumption during the 8-week intervention period (Figure 1) displayed multiple 
significant group effects. Caloric consumption for HF was significantly greater than for CHOW 
(p<0.005), SWITCH (p<0.0001), CR (p<0.005), TRF (p<0.0001), and ADF (p<0.0001). Caloric 
consumption for DF was significantly greater than for CHOW (p<0.005), SWITCH (p<0.0001), 
CR (p<0.005), TRF (p<0.0001), and ADF (p<0.0001). Caloric consumption for CR was 
significantly greater than for ADF (p<0.05). No other effects were noted for caloric 
consumption. 
Anthropometric Data 
 All anthropometric data are presented in Table 4. Change in body mass from baseline to 
post-intervention (Figure 2) displayed several group effects. Change in body mass for HF was 
significantly different from all other groups (p<0.0001). Change in body mass for CHOW 
differed significantly from DF (p<0.0001), TRF (p<0.005), and ADF (p<0.0005). Change in 
body mass for SWITCH was significantly different from CHOW (p<0.0001), CR (p<0.0001), 
TRF (p<0.005), and ADF (p<0.05). 
 The data for change in FM from baseline to post-intervention are presented in Table 4 
and Figure 3. The SWITCH, DF, TRF, and ADF groups displayed decreased FM after the 8-
week intervention, while the CHOW, HF, and CR groups displayed an increase in FM. As 
expected, the HF group gained more FM (6.76±0.46g) than all other groups (p<0.0001). The 
greatest decrease in FM was observed in the SWITCH group, which lost significantly more FM 
(-6.275±0.86g; p<0.005) than all other groups with the exception of DF (-4.10±0.49g; p>0.05). 
Change in FM for CHOW was significantly different from SWITCH (p<0.0001), DF 




different from CR (p<0.0005). No significant differences were observed with regard to change in 
FM between the DF, TRF (-1.89±0.55g), and ADF (-2.39±0.49g) groups. 
 Data for the change in FFM from baseline to post-intervention are displayed in Figure 4. 
No main effect or group effect was noted. However, the change in FFM between HF - which 
gained FFM - and CR - which lost FFM - trended towards significance (p=0.068). 
 Change in %FM from day 1 of the intervention to the final day of the intervention (Figure 
5) displayed several significant group effects. Change in %FM for HF was significantly different 
from SWITCH, DF, CR, TRF, and ADF (p<0.0001). Change in %FM for CHOW was 
significantly different from SWITCH (p<0.0001), DF (p<0.0001), TRF (p<0.0005), and ADF 
(p<0.0001). Change in %FM for SWITCH was significantly different from CR (p<0.0001), TRF 
(p<0.0001), and ADF (p<0.0001). Change in %FM for DF was significantly different from CR 
(p<0.0001) and TRF (p<0.05). Change in %FM for CR was significantly different from ADF 
(p<0.05).  
Run Time to Exhaustion Data 
 Data for the run time to exhaustion are presented in Figure 6. No significant effects were 
noted (p>0.05). However, large effect sizes were observed when comparing DF to HF (d=1.10), 
TRF to HF (d=0.99), and ADF to HF (d=1.10). 
Discussion 
 To our knowledge, this is the first study to compare the effects of dietary protocols 
mimicking caloric restriction, the Daniel Fast, time-restricted feeding, and alternate day fasting 
on measures of body composition and physical performance in male C57BL/6 mice. Our results 
indicate that the CR, DF, ADF, and TRF protocols used in this study produce favorable 




between groups were not significant, the DF, TRF, and ADF groups displayed greater run time to 
exhaustion when compared with the HF group, with large effect sizes noted.  
Anthropometric Findings 
 As can be seen in Table 4 and Figure 2, the SWITCH, DF, CR, TRF, and ADF groups all 
displayed decreased body mass after the 8-week intervention. SWITCH displayed the greatest 
decrease in body mass, losing significantly more weight than all groups besides DF. No 
significant differences were observed with regard to change in body mass between the DF, CR, 
TRF, and ADF groups, indicating that all of these diet regimes are effective for inducing weight 
loss and/or preventing excessive weight gain following a period of high-fat feeding. As expected, 
the CHOW and HF groups exhibited increased body mass after the 8-week intervention. The 
increase in body mass displayed by the CHOW group is characteristic of the normal growth of 
C57BL/6 mice, and the increase in body mass displayed by the HF group is characteristic of the 
growth rate of C57BL/6 mice given ad libitum access to a calorically dense diet.  
 With regard to body composition, the SWITCH, DF, TRF, and ADF groups displayed 
decreased FM (Table 4 and Figure 3) after the 8-week intervention, while the CHOW, HF, and 
CR groups displayed an increase in FM. As noted above, the greatest decrease in FM was 
observed in the SWITCH group, which lost significantly more FM than all other groups with the 
exception of DF. No significant differences were observed with regard to change in FM between 
the DF, TRF, and ADF groups; although, it should be noted that the DF group displayed the 
lowest post-intervention FM despite consuming the most kilocalories during the 8-week 
intervention period (Table 4). These data indicate that the DF, TRF, and ADF protocols used in 
this study can effectively decrease FM following a period of high-fat feeding, albeit likely 




restriction while DF likely modulated FM via the quality of the macro-and-micronutrients 
contained in the purified vegan rodent chow.  
 Figure 4 presents data respective to change in FFM after the 8-week intervention. No 
main or group effects were noted for this data, though the comparison between HF and CR 
trended towards significance (p=0.068). This lack of a significant main effect is likely due to the 
relatively small changes in FFM observed after the 8-week intervention, coupled with the small 
group sizes and the relatively large variation observed (SEM). However, it is worth noting that 
only the CR and ADF groups displayed decreased FFM after the 8-week intervention. Animals 
in the DF and TRF groups actually gained FFM over the course of the 8-week intervention. The 
gain in FFM observed in the DF group is particularly notable because the purified vegan rodent 
chow consumed by the DF group contains only soy protein; it does not contain any animal 
protein. These data demonstrate that the TRF and DF protocols used in this study can maintain 
FFM, even during periods of weight and fat loss.  
 Many of the findings discussed in this section are consistent with the anthropometric 
measures reported by other animal studies that utilized DF, TRF, and ADF dietary protocols. 
Studies have consistently reported significant reductions in body mass following the DF (25), 
TRF (6, 8, 26, 27), and ADF (28-30) protocols in animal models. With regard to body 
composition, the DF (25) and TRF (8, 26) protocols have often resulted in reductions in FM, 
while only one animal study (31) has indicated that ADF results in decreased FM, relative to 
control. However, it should be noted that many of these studies, and all of the ADF studies 
mentioned here, use epididymal FM as a measure of overall FM. The current study measured FM 




The available FFM data relevant to the DF compares well to the data reported in the 
current study. Notably, our previous work with the DF in male Long-Evans rats reported 
maintenance of FFM following 12 weeks of purified vegan rodent chow consumption, despite 
weight loss and decreased FM (25). Measures of FFM have not been reported following TRF or 
ADF protocols in animals. It should be noted, though, that a number of human studies have 
reported reductions in body weight and FM while maintaining FFM following TRF (4, 5) and 
ADF (13, 14, 17) protocols. 
Taken together, the data from the current study and other studies mentioned here indicate 
that DF, TRF, and ADF protocols are capable of producing favorable alterations in body 
composition. The DF appears to produce the best results with regard to anthropometric measures 
of body composition in animal models, though more studies are needed to confirm these 
findings. Additionally, TRF and ADF protocols appear to be viable options for individuals 
seeking to decrease body mass and FM while consuming a Western diet that is high in fat and 
simple sugar. More work is needed to compare the effects of the DF, TRF, and ADF on 
measurements of body composition. 
Run Time to Exhaustion Findings 
 As indicated by Figure 6, no main or group effects were observed for the run-time-to-
exhaustion test. The lack of a significant main effect in these data is likely due to the small group 
sizes and the relatively large standard error observed. Additionally, the animals’ genetic aerobic 
capacity likely affected run time to exhaustion. For example, during our run-time-to-exhaustion 
tests, many of the animals had difficulty running at the predetermined testing speed, even during 
the early stages of testing (20m/min). It may be that some of these animals simply possessed 




Despite the lack of a significant main effect, however, it is valuable to highlight the mean 
values for the main intervention groups. The mean run time for the DF (39.00±2.90min), TRF 
(40.00±4.88min), and ADF (27.78±3.30min) groups was greater than the mean run time for the 
HF group (16.38±3.85min). Additionally, large effect sizes were observed when the mean run 
time for the DF (d=1.10), TRF (d=0.99), and ADF (d=1.10) groups were compared with the HF 
group. These data indicate that the DF, TRF, and ADF protocols had a large impact on run time 
to exhaustion performance, when compared with the HF group. This may be attributed to the 
relatively higher FM of the HF group. Further, because the mean run time for the DF and TRF 
groups closely resembled the mean run time for the CHOW group (39.86±7.87min), the DF and 
TRF dietary appear to optimize performance, relative to ADF. 
 As mentioned above, literature describing the effects of DF, TRF, and ADF on physical 
performance is scant. Only one known study has reported any measure of physical performance 
following a DF intervention in animals (25). Conducted in male Long-Evans rats, this study 
indicated the DF combined with regular exercise results in significantly greater aerobic 
performance than a high-fat diet combined with regular exercise. However, run time between the 
DF and high-fat groups that did not participate in regular exercise did not differ significantly, 
findings that align well with the findings of the current study. With regard to TRF studies in 
animals, one study (11) has reported that C57BL/6J mice following TRF protocols display 
significantly greater run time to exhaustion, relative to a high-fat control, and another study has 
indicated that TRF improves physical performance (as measured by flight index) in Drosophila 
(10). Additionally, studies have indicated that TRF does not diminish physical performance in 




measurement of physical fitness following an ADF intervention. More work is needed to 
investigate the impacts of DF, TRF, and ADF on measures of physical performance. 
Conclusions 
 To our knowledge, this is the first study to compare the effects of dietary protocols 
mimicking caloric restriction, the Daniel Fast, time-restricted feeding, and alternate day fasting 
on measures of body composition and physical performance in male C57BL/6 mice. The 
findings presented here indicate that the Daniel Fast, time-restricted feeding, and alternate day 
fasting are viable option for improving anthropometric measures and physical performance, 
when compared with an ad libitum high-fat diet. 
Future Directions 
Future research using animal models and human participants are needed to more fully 
elucidate the mechanisms responsible for the improved anthropometric measures in response to 
the Daniel Fast, time-restricted feeding, and alternate day fasting. Specifically, research should 
focus on the caloric consumption of each group and relate it to changes in anthropometrics. For 
example, in the present study, the Daniel Fast group consumed the greatest number of 
kilocalories during the intervention period, yet the Daniel Fast group also had the lowest FM. 
Future research should determine the causes of the noted changes and seek to address these 
results more specifically.  
Additionally, future studies should aim to better characterize the effects of the Daniel 
Fast, time-restricted feeding, and alternate day fasting on physical performance, both in an 
animal model and with human participants. These studies should use larger sample sizes than 
what was used in the present study to better mitigate the effects of within group variation in 




tests to measure changes in physical performance after the completion of the dietary 
interventions. Additionally, future studies aiming to characterize physical performance following 
DF, TRF, and ADF should likely aim to control body mass between groups to better measure the 
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Figure 1. Total kilocalories consumed during the 8-week intervention period by male mice 
assigned to seven different dietary protocols. 
 
Values are Mean ± SEM 
 
* A group effect noted for caloric consumption: HF>CHOW, SWITCH, CR, TRF, & ADF 
(p<0.005) 
† A group effect noted for caloric consumption: DF>CHOW, SWITCH, CR, TRF, & ADF 
(p<0.0005) 

































Figure 2. Change in total body mass (g) from baseline (start of the intervention) to the last day of 
the 8-week intervention of male mice assigned to seven different dietary protocols. 
 
Values are Mean±SEM 
 
§ A group effect noted for change in body mass: CHOW different from SWITCH, DF, TRF, & 
ADF (p<0.005) 
* A group effect noted for change in body mass: HF different from all groups (p<0.0001) 































Figure 3. Change in FM (g) from baseline (start of intervention) to the last day of the 8-week 
intervention of male mice assigned to seven different dietary protocols.  
 
Values are Mean±SEM 
 
§ A group effect noted for change in FM: CHOW different from SWITCH, DF, TRF, & ADF 
(p<0.005) 
* A group effect noted for change in FM: HF different from all groups (p<0.0001) 
¥ A group effect noted for change in FM: SWITCH different from CR, TRF, & ADF (p<0.0005)  






























Figure 4. Change in FFM (g) from baseline (start of intervention) to the last day of the 8-week 
intervention of male mice assigned to seven different dietary protocols.  
 
Values are Mean±SEM 
 












































Figure 5. Change in percent fat mass (%FM) from baseline (start of intervention) to the last day 
of the 8-week intervention of male mice assigned to seven different dietary protocols.  
 
Values are Mean±SEM 
 
§ A group effect noted for change in %FM: CHOW different from SWITCH, DF, TRF, & ADF 
(p<0.0005) 
* A group effect noted for change in %FM: HF different from SWITCH, DF, CR, TRF, & ADF 
(p<0.0001) 
¥ A group effect noted for change in %FM: SWITCH different from CR, TRF, & ADF 
(p<0.0001)  
† A group effect noted for change in %FM: DF different from CR & TRF (p<0.05) 































Figure 6. Run time to exhaustion (min) in male mice assigned to seven different dietary protocols 
for 8 weeks.  
 
Values are Mean±SEM 
 
While no main or group effects were observed (p>0.05), all groups demonstrated a higher mean 




Table 1. Macronutrient composition and Caloric Density of Experimental Diets. 
Macronutrient DF HF CHOW 
  kcal% kcal% kcal% 
Protein 15 20 24  
Carbohydrate 59 35 58  
Fat 25 45 18  
    
kcal/gm 3.9 4.73 3.1 
 
Table 2. Ingredient List of Daniel Fast and High-Fat Diets 
 
  DF HF 
 gm kcal gm kcal 
Casein 0 0 200 800 
Soy Protein 170 680 0 0 
DL-Methionine 3 12 0 0 
Corn Starch 0 0 72.8 291 
Corn Starch-Hi Maize 
260 533.5 2134 0 0 
(70% Amylose and 30% 
Amylopectin) 
    
Maltodextrin 150 600 100 400 
Sucrose 0 0 172.8 691 
L-Cystine 0 0 3 12 
Cellulose, BW200 100 0 50 0 
Inulin 50 50 0 0 
Soybean Oil   25 225 
Lard 0 0 177.5 1598 
Flaxseed Oil 71 639 0 0 
Safflower Oil, High Oleic 59 531 0 0 
Ethoxyquin 0.04 0 0 0 
DiCalcium Phosphate   13 0 
Mineral Mix S10001 35 0 10 40 
Calcium Carbonate 4 0 5.5 0 
Mineral Mix S10026   10 0 
Vitamin Mix V10001 10 40 0 0 
Choline Bitartrate 2 0 2 0 
Ascorbic Acid Phosphate, 
33% active 0.41 0 0 0 
Potassium Citrate, 1 H2O 0 0 16.5 0 
Cholesterol 0 0 0 0 




Table 3. Macronutrient and Micronutrient Composition of Standard Rodent Chow 
 
Micronutrients     Amino Acids 
Calcium % 1 Aspartic Acid % 1.4 
Phosphorous % 0.7 Glutamic Acid % 3.4 
Non-Phytate Phosphorous % 0.4 Alanine % 1.1 
Sodium % 0.2 Glycine % 0.8 
Potassium % 0.6 Threonine % 0.7 
Chloride % 0.4 Proline % 1.6 
Magnesium % 0.3 Serine % 1.1 
Zinc mg/kg 70 Leucine % 1.8 
Manganese mg/kg 100 Isoleucine % 0.8 
Copper mg/kg 15 Valine % 0.9 
Iodine mg/kg 6 Phenylalanine % 1 
Iron mg/kg 200 Tyrosine % 0.6 
Selenium mg/kg 0.23 Methionine % 0.4 
Vitamins    Cysteine % 0.3 
Vitamin A e,f IU/g 15 Lysine % 0.9 
Vitamin D3  e,g IU/g 1.5 Histidine % 0.4 
Vitamin E IU/kg 110 Arginine % 1 
Vitamin K3 (menadione) mg/kg 50 Tryptophan % 0.2 
Vitamin B1 (thiamin) mg/kg 17 Fatty Acids     
Vitamin B2 (riboflavin) mg/kg 15 C16:0 Palmitic % 0.7 
Niacin (nicotinic acid) mg/kg 70 C18:0 Stearic % 0.2 
Vitamin B6 (pyridoxine) mg/kg 18 C18:1ω9 Oleic % 1.2 
Pantothenic Acid mg/kg 33 C18:2ω6 Linoleic % 3.1 
Vitamin B12 
(cyanocobalamin) 
mg/kg 0.08 C18:3ω3 Linolenic % 0.3 
Biotin mg/kg 0.4 Total Saturated % 0.9 
Folate mg/kg 4 Total Monounsaturated % 1.3 






Table 4. Anthropometric and run time to exhaustion data for male mice assigned to seven 
different dietary protocols for 8 weeks.  
 
  






%FM Run time to 
exhaustion  
(min) 
 PRE POST PRE POST PRE POST PRE POST POST 
CHOW 25.49±0.66 27.79±1.03 2.48±0.38 4.21±0.71 21.05±0.48 21.30±0.39 0.10±.0.1 0.15±0.02 39.86±7.87 
HF 30.54±1.01 39.60±1.71 7.96±0.72 14.72±0.92 20.64±0.37 22.03±0.85 0.26±0.02 0.37±0.01 16.38±3.85 
SWITCH 33.90±0.79 28.65±0.83 10.71±0.68 4.43±0.89 21.20±0.34 22.02±0.34 0.31±0.01 0.15±0.03 42.13±9.01 
DF 31.83±1.02 28.91±0.5 7.82±0.84 3.72±0.44 21.97±0.57 22.85±0.76 0.24±0.02 0.13±0.01 39.00±9.4 
CR 34.12±1.05 33.69±1.01 10.55±0.82 10.56±0.62 21.50±0.30 20.78±0.86 0.31±0.02 0.31±0.01 30.63±5.38 
TRF 30.03±1.06 28.47±0.63 7.80±0.89 5.91±0.51 20.31±0.31 20.50±0.26 0.25±0.02 0.21±0.01 40.00±10.68 
ADF 30.96±0.56 28.64±0.40 7.75±0.63 5.36±0.35 21.13±0.23 20.91±0.38 0.25±0.02 0.19±0.01 27.78±3.30 
 







The prevalence of obesity - a complex condition caused by a combination of genetic, 
metabolic, social, behavioral, and cultural factors - has risen substantially in the United States since 
the year 1976 (1). As of 2014, the WHO estimated that, worldwide, 35% of adults over the age of 
20 years were overweight (body mass index [BMI] ≥ 25 kg∙m-2), with 10% of men and 14% of 
women being classified as obese (BMI ≥ 30 kg∙m-2) (2). The United States exhibits particularly 
high levels of overweight and obesity. More than one in three (36.5%) adult Americans is classified 
as obese (3). More than two in three (69.2%) adult Americans are classified as either overweight 
or obese. In Americans, obesity is more prevalent in non-Hispanic blacks (48.1%) and Hispanics 
(42.5%) when compared to both the national average and non-Hispanic whites (34.5%), and non-
Hispanic Asians (11.7%). Additionally, obesity is more prevalent in older adults than in younger 
adults: the prevalence of obesity in Americans ages 40-59 (40.2%) and Americans age 60 and 
older (37.0%) is generally greater than the prevalence of obesity individuals age 20-39 (32.3%). 
Perhaps more troubling, these trends extend to the youth of America. The Centers for Disease 
Control and Prevention (CDC) estimate that 12.7 million (17%) American adolescents age 2-19 
suffer from obesity (defined as BMI in kg∙m-2 greater than or equal to the age- and sex-specific 
95th percentile of the 2000 CDC growth charts).  
 Obesity places a major financial burden on the healthcare system of the U.S. In 2011, Tsai 
et al. estimated that overweight status and obesity accounted for $170.2 billion U.S. dollars (7.1%) 




doubled or tripled the percentage of healthcare dollars spent to combat obesity in several other 
developed nations, including Canada and nations in the European Union (4). Unfortunately, the 
future looks even bleaker. Experts have projected direct healthcare costs for preventing, 
diagnosing, and treating overweight and obesity will rise to 16-18% of total healthcare dollars 
spent in the U.S. by the year 2030. 
 In addition to causing a great national financial burden, obesity may substantially reduce 
an individual’s quality of life, impacting physical, psychological, and financial functioning (5). 
Obese individuals often experience some degree of decreased physical and psychological function. 
Notably, aerobic and anaerobic capacity, ability to perform basic tasks, ability to perform at work, 
and ability to sleep (including the development of sleep apnea) may decline with obesity (6-10). 
These decreases in physical function may be accompanied by, or compounded by, some 
combination of feelings of depression, shame, guilt, and social isolation, as well as other potential 
psychological stressors (5, 11-13). Moreover, because obesity has been linked to cardiovascular 
disease (CVD) (14, 15), type II diabetes (16), and some forms of cancer (including colon, kidney, 
endometrial, and postmenopausal breast cancers) (17, 18), individuals may have no choice but to 
spend a substantial amount of money to assuage the negative healthcare outcomes associated with 
obesity. Studies have estimated that obese individuals spend as much as $1429-$1723 more per 
year on healthcare when compared to individuals of normal weight (BMI between 18 and 25 kg∙m-
2) (4, 19). 
Weight Loss Strategies 
 The figures and statistics listed above make it clear that obesity is a major healthcare 
problem, and an intervention is needed. Several strategies exist that may help an individual lose 




activity/exercise, may be implemented by an individual at home. Dietary modification can 
effectively stimulate weight loss in obese individuals (discussed in further detail below). Exercise, 
of sufficient volume and intensity, has also been shown to decrease fat mass and, thus, BMI (20).  
The second tier of weight loss strategies requires intervention by healthcare professionals. 
These methods should be employed after the first tier of intervention has been deemed 
unsuccessful with regards to obtaining the needed weight loss/health outcomes. These strategies 
include weight-loss counselling by a registered dietitian or a counselor, as well as consideration 
for the use of prescription weight-loss drugs. The Food and Drug Administration (FDA) has 
approved several drugs designed to induce weight loss, including lorcaserin and phentermine–
topiramate, which have been shown to assist individuals with weight loss goals (21). 
The third and final tier consists of bariatric surgeries. These surgeries, such the 
Laparoscopic Adjustable Gastric Banding (LAGB), Laparoscopic Sleeve Gastrectomy (LSG), and 
Roux-en-Y Gastric Bypass (RYGB), are typically reserved for individuals with extremely high 
BMIs (BMI > 40 kg∙m-2). These surgeries should be considered as a last resort for those seeking 
weight loss and should be reserved for those who have medical conditions secondary to being 
obese.  However, they have been shown to be extremely effective in individuals who have extreme 
trouble with losing weight.   
 The intervention that is most applicable to the average obese person include lifestyle 
modification, involving increased physical activity and diet modification. Perhaps the most 
recognizable form of diet modification is caloric restriction. Caloric restriction (CR) consists of 
restricting the number of calories consumed per day. Typically, CR attempts to reduce caloric 
intake by 20-40% of ad libitum consumption, achieved by consuming a reduced volume of food 




markers (22-24). Because of the low tolerability of CR in human populations (25), researchers and 
healthcare professionals have developed indirect methods to achieve caloric restriction that are 
better tolerated by humans. One such method is intermittent fasting (IF). IF is a general term that 
describes any dietary modification in which an individual intentionally alternates between periods 
of “feeding” and extended, self-induced “fasting” (26). Two notable methods of IF have emerged: 
time-restricted feeding (TRF) and alternate day fasting (ADF). TRF restricts daily feeding periods 
to designated hours of the day (i.e. only eating from 12:00 pm – 7:00 pm), extending the typical 
overnight fast by several hours. TRF often, but not always, reduces  daily caloric intake by 
reducing feeding time. Alternate day fasting (ADF) is the practice of fasting for one day, followed 
by ad libitum consumption on the subsequent day. Although it has been documented that 
individuals practicing ADF typically increase caloric intake on the feeding days, net calorie 
ingestion is typically lowered over the total duration of the regime (27).  
For many individuals, CR is intolerable for extended periods of time. Dietary restriction 
(DR) may be more tolerable to these individuals. DR is a dietary modification in which an 
individual reduces or eliminates the consumption of specific dietary components (28). DR 
commonly involves the reduction of a specific macronutrient (carbohydrates, lipids, or proteins). 
Vegetarian diets, ketogenic diets, and the Daniel Fast (DF) are examples of DR. The DF is a 
religiously motivated DR, derived from the Bible. As described in the book of Daniel, the DF is a 
strict vegan diet, consisting of only of pulse (food grown from seeds) (29). Today, a typical DF 
consists of the ad libitum consumption of vegetables, whole grains, nuts, legumes, seeds, and 
healthy oils. It prohibits the consumption of processed foods, coffee, and alcohol. Individuals 




Time-restricted feeding, alternate day fasting, and the Daniel Fast have been shown to 
improve many markers of health and longevity (29-31). However, relative to caloric restriction, 
time-restricted feeding, alternate day fasting, and the Daniel Fast have not been studied in great 
detail, especially with regard to changes in body composition and physical fitness (e.g., endurance 
capacity). Because body composition and physical fitness are important markers of overall health, 
it is important to compare TRF, ADF, and DF in a single study to determine the relative 
effectiveness of each dietary modification these outcomes. To the author’s knowledge, no such 
study has been conducted.  
This review will discuss the relevant literature regarding TRF, ADF, and DF and the health 
benefits associated with each. It will also discuss measures of body composition and physical 
fitness and their relation to overall health and TRF, ADF, and DF.  
Body Composition 
The term “body composition” describes the chemical composition of the body. The human 
body is composed of muscle mass, connective tissue, organs, bone, adipose tissue, and water. 
Because it is difficult to measure the contribution of each of these components to overall body 
composition through traditional methods, conventional measurements of body composition often 
group the components of the human body into two gross categories: fat mass (FM) and fat-free 
mass (FFM). Muscle mass, connective tissue mass, organ mass, and bone mass are collectively 
termed FFM, while all adipose tissue is termed FM. Assessments of body composition attempt to 
measure the relative percentages of FFM and FM and are often expressed simply in terms of 
percent fat-free mass (%FFM) versus percent fat mass (%FM).  
Body composition can either be directly measured or estimated. Cadaver analysis and 




[MRI], and dual-energy x-ray absorptiometry [DXA]) are the only methods currently available to 
directly measure total body composition. Cadaver analysis is considered the gold standard of body 
composition assessment, which is obviously restricted only to use in animal models (32). Thus, 
diagnostic imaging is the best method for assessing body composition in living humans. Currently, 
many investigators use DXA due to its validity and reliability (33). Body composition may also 
be estimated through various methods, including bioelectrical impedance analysis (BIA), 
densitometry (hydrostatic weighing, water displacement, air plethysmography), and 40pattasium 
counting. Moreover, anthropometric measurements such as waist circumference and skinfold 
thickness measurements are often used in large populations to estimate body composition, as these 
assessments are quick to perform and inexpensive. However, estimates of body composition are 
typically, but not always, less reliable than diagnostic imagery (34). 
Body Composition and Overall Health   
 Body composition an important indicator of overall health. A high percentage of FM (% 
FM) is closely correlated to elevated BMI (1). In turn, elevated BMI is associated with a number 
of negative health outcomes. Obese individuals (BMI ≥ 30 kg∙m-2) present with increased CVD 
risk factors, including hypertension, dyslipidemia, insulin resistance, and type II diabetes mellitus 
(14). Ultimately, an increase in CVD risk factors leads to increased incidence of CVD-related 
events in obese individuals, such as myocardial infarction, heart failure, sudden death, coronary 
heart disease, and ischemic stroke (14, 35, 36). 
 Abdominal obesity, or visceral obesity, is another important measurement of body 
composition. Measured by DXA and CT scan, or estimated via waist circumference, abdominal 




myocardial infarction, and heart failure (37). Weight loss strategies that reduce abdominal obesity 
should be prioritized.  
FFM can also be an important indicator of overall health because FFM is the single best 
predictor of resting metabolic rate (38). Resting metabolic rate (RMR) - a measurement of resting 
energy expenditure - accounts for 60-70% of total daily caloric expenditure, depending on physical 
activity (39). Because energy expenditure must exceed energy intake to induce weight loss, RMR 
and its influence on energy homeostasis should be considered in models of weight loss. Indeed, 
researchers have hypothesized that abnormally low RMR is a strong indicator of future weight 
gain (40). It has been known for some time that FFM is the single best predictor of RMR (38). In 
fact, FFM explains between 60-80% of the variance in measured RMR (41). Additional 
adjustments for specific components of FFM such as organ volume and density can push this R2 
value to as high as 85% (42, 43). Thus, dietary interventions that result in weight loss but maintain 
FFM should be prioritized.  
Body Composition and Physical Fitness 
 Body composition is an independent predictor of physical fitness. Tests of physical fitness 
often involve moving one’s body (i.e. running) as long or as fast as possible. FFM (skeletal muscle) 
performs the work during such tests. Underweight individuals (BMI < 18 kg∙m-2) with low levels 
of FFM may display worse fitness than normal weight individuals (6). Because FM is not 
responsible for performing human work, FM may be viewed as “dead weight” during physical 
activity. Individuals must simply carry this extra weight during physical fitness tasks and 
examinations, similar to wearing a backpack while running. For obvious reasons, it is logical that 
increased FM will have a detrimental impact on physical performance/fitness. Indeed, physical 




adults (7, 8). Additionally, studies have shown a negative correlation between body fatness and 
performance in activities requiring running or jumping (44, 45). Therefore, generally, it can be 
said that individuals with abnormally high or low BMIs may display lower fitness than individuals 
of normal BMI.   
Body Composition and Dietary Modification 
 Body composition can be altered significantly through dietary modification. Certainly, 
many dietary modifications have been created for the sole purpose of decreasing total body mass 
and FM. Caloric restriction has been shown to positively change body composition by decreasing 
total body mass and FM (46, 47). Additionally, studies have reported that CR decreases abdominal 
subcutaneous (48), visceral (48, 49), and intermuscular fat (48, 49). However, studies have also 
indicated that CR significantly decreases FFM (49). For this reason, CR interventions may 
recommend consumption of a high-protein diet. CR with a high protein diet shows promise in 
maintaining FFM during CR-induced weight loss (50), although it should be understood that 
reducing caloric intake will almost certainly lead to some loss in FFM.  
 TRF also displays the potential to reduce total body mass and FM while maintaining FFM. 
To the author’s knowledge, three studies have examined the relationship between TRF and body 
composition in humans. One study  failed to report significant differences in total body mass, FM, 
or FFM following a TRF intervention (51), while the other two studies reported extremely 
favorable body composition outcomes (52, 53). The most successful study found that participants 
in the TRF group lost significantly more FM compared to the control group when measured at the 
conclusion of the 8-week intervention (−16.4 in TRF vs −2.8 %FM in control). Moreover, despite 
losing significantly more FM, the TRF group did not differ from baseline or between groups for 




evidence suggests that TRF is successful in maintaining FFM during weight loss, no studies have 
measured body composition in overweight or obese individuals following TRF.  
 Relative to simple CR, ADF also seems to have the potential to induce favorable changes 
in body composition in humans. Similar to simple CR, ADF has been shown to result in significant 
reductions in FM (54-59), visceral FM (58), and waist circumference (57, 60). However, whereas 
simple CR often results in loss of FFM, modified ADFs have demonstrated the ability to maintain 
FFM during weight loss. Three out of four studies that have measured FFM have reported no 
significant reductions in FFM relative to baseline (55, 57) or relative to a control group (56) 
following the completion of a modified ADF protocol. It should be noted that while individuals 
appear to retain FFM relatively well during modified ADF, traditional ADF has resulted in 
significant reductions in FFM during ADF (54, 59).  
 Alternatively, DF has not resulted in favorable body composition alterations in humans. 
Only one study has displayed significant reductions in total body mass and/or FM (61). Following 
a 21-day DF intervention with krill oil supplementation, body weight (74.1 ± 2.4 versus 71.5 ± 2.3 
kg), fat mass (21.9 ± 1.5 versus 20.8 ± 1.5 kg), and fat-free mass (52.2 ± 2.0 versus 50.8 ± 1.9) all 
decreased significantly, relative to baseline. However, neither a traditional DF or a modified DF 
(inclusion of one serving of meat and one serving of dairy per day) has resulted in significant 
reductions in any measure of body composition (29, 62, 63). The lack of findings of significant 
weight loss in these studies is likely due to the short duration of the intervention (21 days). 
Physical Fitness 
Generally, physical fitness is defined as the ability to perform physical activity (64). It is 
characterized by a number of subcategories, including cardiorespiratory fitness, muscular fitness, 




classified anywhere from low fitness to highest fitness based on performance in a number of 
physical performance examinations (65). Many intrinsic factors such as age, sex, race, motivation, 
and genetic expression influence physical fitness. Extrinsic factors also influence physical fitness, 
most notably regular physical exercise (66).   
Cardiorespiratory fitness and muscular fitness are the most important components of 
health-related physical fitness. Cardiorespiratory fitness (CRF) is broadly defined as the overall 
combined ability of the body’s cardiovascular and respiratory systems to uptake, transport, and 
use oxygen (67). The most accurate measure of CRF is maximal oxygen uptake during an exercise 
performance test (VO2max) (68). Measurements of VO2max can either be obtained directly or 
indirectly. Direct measurement of VO2max involves the collection of an individual’s expired gases 
using the Douglas Bag method or automated gas-collection equipment such as a metabolic cart. 
The composition of the expired gas is analyzed to determine total oxygen uptake at the point of 
volitional failure. Indirect measurement of VO2max involves the estimation of VO2max using an 
exercise test. Graded exercise tests, such as a step-up test or a submaximal walk test, are frequently 
used in clinical settings. A variable (i.e. time or heart rate) is measured upon the completion of the 
exercise test. The value of this variable is then plugged into an adjusted equation to estimate 
VO2max. Other exercise tests, such as the 1.5 mile run test and the run-time-to-exhaustion test, 
provide meaningful descriptive data related to CRF.     
Muscular fitness is characterized by the strength and endurance of skeletal muscle. A 
variety of tests have been used to assess muscular fitness. These tests include maximal pushups 
achieved during a given time frame, maximal sit-ups achieved during a given time frame, maximal 




exercise (i.e. bench press). Studies have not determined a single test of muscular capacity that best 
estimates overall muscular fitness.  
Physical Fitness and Overall Health 
 Studies have routinely reported CRF to be an important predictor in overall health for a 
multitude of populations. Low CRF leads to decreased ability to perform seemingly-simple daily 
activities. Additionally, low CRF appears to be a powerful independent risk factor for all-cause 
mortality in both healthy and non-healthy populations (65, 69-71). Studies have also shown an 
inverse relationship between CRF and the risk of developing sudden cardiac death (72), cancer 
mortality (73), childhood obesity (74, 75), type 2 diabetes mellitus (76, 77), and cardiovascular 
disease (78). Similarly, studies have reported a positive relationship between CRF and cognition 
(79) and health-related quality of life (80). 
Because low CRF is associated with adverse outcomes and high CRF is associated with 
positive outcomes, improving CRF is perhaps the most important fitness goal for the average 
individual. Fortunately, studies have repeatedly demonstrated that regular exercise improves CRF 
(66, 81). Moreover, drastic improvements in CRF may not be required to induce clinically 
meaningful improvements in health-related outcomes, as indicated by Kokkinos et al. In one study 
conducted by Kokkinos et al., they examined the relationship between CRF and mortality risk in 
6,749 black and 8,911 white men. CRF was measured in metabolic equivalents (METs) (65). One 
MET was defined as the energy expended at rest by an average individual (estimated to be 3.5 
mL∙kg-1∙min-1). The study reported that a 1-MET increase in exercise capacity resulted in a 13% 
reduction in risk of mortality for individuals with and without cardiovascular disease. Small 
improvements such as these may also lead to increased ability to perform basic daily tasks, 




Compared to CRF, research on the role of muscular fitness and overall health is limited. 
Muscular fitness is important for maintaining individual autonomy (82). Simple tests of muscular 
fitness such as the sit-stand provide valuable indicators of an individual’s functional muscular 
fitness. Individuals that perform extremely poorly on these functional fitness exams will likely 
experience difficulty performing everyday tasks, a general characteristic of extreme obesity. 
Moreover, muscular fitness may be an important indicator of general health. Muscular fitness has 
been inversely linked to several adverse outcomes, including all-cause mortality (83, 84) and 
premature death (85).Therefore, improving muscular fitness should also be a goal for all 
individuals.  
As mentioned above, physical fitness is closely associated with body composition which 
is also associated with overall health. Underweight individuals (BMI < 18 kg∙m-2) may be less fit 
than normal weight individuals (6, 86). On the other end of the spectrum, high BMI has been 
associated with poor physical fitness (6-8). To maximize most measures of physical performance, 
individuals should strive to maintain normal body weight and health levels of FM. 
Physical Fitness and Dietary Modification 
 Diet plays a major role in physical fitness. Relative to ad libitum feeding, CR appears to 
improve physical performance in mice (87, 88), likely because weight gain is inversely related to 
physical performance (6). High-carbohydrate diets have been recommended for prime physical 
performance because they are said to keep glycogen stores saturated and blood concentrations of 
triacylglycerides and free-fatty acids low (89, 90). Two recent reviews indicated that consumption 
of a high-fat diet may result in diminished physical performance, especially at high intensities and 
in anaerobic conditions (91, 92). Therefore, it appears that a high-carbohydrate diet augments 




Few studies have examined the effects of DF, ADF, or TRF on physical performance. To 
date, only one study has examined the relationship of the DF and physical fitness. Following the 
conclusion of a 3-month DF and exercise intervention in male rats, cardiorespiratory fitness was 
measured (run-time-to-exhaustion) and compared to baseline fitness (Bloomer, In Publication). 
Exercise capacity increased significantly more (99% increase) in the DF + exercise group when 
compared to the WD + exercise group (51% increase), indicating that the DF accentuated exercise 
gains. To this author’s knowledge, only 3 studies (excluding studies that focused on Ramadan) 
have examined the relationship of TRF and physical fitness. Two studies have tested the effects of 
TRF in humans. Both of these studies utilized 8-week interventions and similar intervention groups 
(TRF + resistance training 3 x weekly) and control groups (normal diet + resistance training 3 x 
weekly) (51, 53). Neither study reported significant differences between groups in physical 
performance as measured by muscular strength or endurance (51, 53). One study examined the 
effects of TRF on physical performance in animals. This study reported that Drosophila subjected 
to TRF displayed significantly better flying performance, relative to the control group (93). No 
publications have studied ADF and physical fitness. More research is needed in humans and 
animals to determine whether TRF, ADF, and DF will enhance physical fitness. 
Time-Restricted Feeding 
 Intermittent fasting (IF) is a general term that describes any dietary modification in which 
an individual intentionally alternates between periods of “feeding” and extended, self-induced 
“fasting” (26). During the feeding period, individuals are often permitted to consume foods ad 
libitum (51, 59, 94), although some IF interventions have restricted caloric intake during the 
feeding period (53, 95). During the fasting period, individuals either abstain from caloric intake 




periods can last anywhere from 12 hours (99) to 48 hours (97) or longer, and the duration of this 
period typically demarcates the classification of each IF regime. Recently, two types of IF have 
recently garnered noteworthy interest from the scientific community. 
In recent decades, alternate day fasting (ADF) and time-restricted feeding (TRF), two 
specific types of IF, have gained scientific momentum. ADF involves the cycling of 24-hour ad 
libitum feeding with 24-hour fasting or severe caloric restriction (26). Alternatively, TRF – the 
topic of this section - simply involves the daily reduction of the feeding period. Typical TRF 
interventions limit the daily feeding period to a 4-12 hour window in the afternoon/evening, 
eliminating any caloric consumption during the morning and night hours. This results in a 
lengthened fasting period (12-20 hours per day). However, during feeding periods, individuals are 
allowed ad libitum caloric consumption. Additionally, TRF does not necessarily mandate that 
individuals “improve” their diet, only alter their meal timing. For these reasons, TRF is viewed as 
a very user-friendly alternative to individuals who find it difficult to adhere to the guidelines of 
simple CR.  
Time-Restricted Feeding: Overview of Current Literature 
Human Trials 
 Few publications have examined the effects of controlled TRF interventions in a human 
model. However, despite utilizing short-term TRF interventions lasting between 2-8 weeks and 
some conflicting results, these studies have displayed promise. Many benefits have been associated 
with TRF, including - but not limited to – reduction of caloric intake (51), weight loss (52, 53), 
decreased FM (52, 53). Positive alterations in blood lipids following TRF such as increased HDL 
(52) and decreased triglycerides (53) have been noted. Additionally, TRF has been associated with 




Ramadan-fasting-induced TRF have reported similar positive results (100-104). Furthermore, 
studies indicate that TRF, especially 16/8 (16 hour fasting period/8 hour feeding period) TRF, is 
well tolerated by participants (53). 
Currently, few negative or conflicting results have been reported in regards to TRF. Carlson 
and colleagues stated that an 8-week TRF intervention (1 iso-caloric [relative to control group] 
meal per day consumed between 5:00pm – 9:00pm) resulted in increased morning blood glucose 
concentrations and decreased glucose tolerance (105). The authors suggested that the increase in 
blood glucose levels could be a result of the study’s design, stating that early-morning blood 
glucose levels were likely impacted by the consumption of extremely calorically dense 
intervention meal the during the preceding night. The duration of period may have also influenced 
this outcome. Longer feeding periods (6-8 hours) may improve measures of glucoregulation, as 
displayed by the findings of Moro et al. (53). Additionally, Tinsley et al. indicated that an 8-week 
TRF intervention (4-hour ad libitum feeding period between 4:00pm – 8:00pm) may lead to 
decreased hypertrophic gains in untrained males relative to untrained males following the same 
resistance training protocol but consuming food ad libitum (51). Thus, TRF may not be appropriate 
in the early stages of resistance training when hypertrophy is the main goal. However, it should be 
noted that TRF has been reported to maintain FFM during weight loss and resistance training (51-
53).  
Animal Trials 
 Animal trials have largely corroborated many of the beneficial findings of human trials 
discussed above. TRF in animals appears to be an effective method for preventing weight gain 
and/or inducing weight loss in a number of species, including Drosophila (93), mice (99, 106-




weight gain can be achieved through TRF despite consumption of at high-fat diet (99, 107). Studies 
have indicated that TRF is successful in improving important lipid factors, such as lowering total 
cholesterol (107, 108, 113) and triglycerides (107, 109). TRF has also been noted to improve 
glucoregulatory factors by lowering plasma insulin levels and increasing insulin sensitivity (107, 
108). Studies have also reported diminished levels of inflammatory markers following TRF (107, 
108). 
It should be noted that not all animal trials have yielded exclusively positive results. Some 
studies have failed to report differences in weight gain post-TRF, relative to a control group (114, 
115). Additionally, not all studies have demonstrated significant improvements in glucoregulatory 
factors following TRF (115). In fact, Park et al. stated that TRF exacerbated hepatic insulin 
resistance, despite loss of FM, in hormone-sensitive lipase knockout mice (115). These discrepant 
results may be the result of a number of factors. In some cases, small sample sizes may have limited 
statistical power, diminishing the opportunity to find significant differences between groups (114). 
In other cases, differences in reported outcomes may be attributed to differences is protocols, as 
studies have used various animal models (i.e. hormone-sensitive lipase knockout mice vs wild-
type mice), interventions of differing lengths (i.e. a 4-week intervention v. a 12-week intervention), 
and daily feeding periods of differing lengths (i.e. a 4-hour feeding period versus a 12-hour feeding 
period).  
Time-Restricted Feeding and Physical Fitness  
Human Trials 
Two studies have examined the effects of TRF on physical fitness in humans, both utilizing 
tests of muscular fitness. Tinsley and colleagues utilized an 8-week TRF in combination with 




consumed a modified TRF diet, while the control group continued to consume their normal diet 
throughout the duration of the study. Both the control group and the intervention group completed 
resistance training (8-12 repetitions to failure) on non-consecutive days 3 x weekly, alternating 
between lower-body and upper-body sessions. Maximal muscular output – classified by maximal 
muscular strength and maximal muscular endurance – was measured at base-line and post-
intervention. Maximal strength was defined by maximal weight achieved during 1-repetition 
(1RM) during the hip sled and barbell bench press exercises. Muscular endurance was defined by 
maximal repetitions using a standardized weight during the hip sled and barbell bench press 
exercises. Relative to baseline, hip-sled endurance, bench-press endurance, and hip sled strength 
increased, post-study. However, no differences existed between groups.  
A second study focused on TRF in resistance-trained men (n = 34). Moro and colleagues 
implemented a 16/8 TRF intervention (16 fasting period; 8 hour feeding period between 1:00pm-
9:00pm; meals consumed at 1:00pm, 4:00pm, and 8:00pm) in combination with 3 x weekly 
resistance training (split routine; 6-8 repetitions to failure) (53). The control group was instructed 
to consume meals at standard times (1:00pm, 4:00pm, and 8:00pm) in combination with 3 x weekly 
resistance training (split routine; 6-8 repetitions to failure). Muscular strength was measured at 
baseline and post-intervention. Muscular strength was defined as 1RM achieved during leg press 
and bench press exercises. Moro et al. reported that weight achieved during 1RM for leg press 
increased in both groups, relative to baseline. However, no differences existed between groups. 
1RM achieved during bench press did not differ from baseline or between groups. 
Taken together, these studies indicate that short-term TRF interventions do not inhibit 
anaerobic muscular performance during resistance training. These data are generally supported by 




Ramadan (116). More research is needed in this area to verify that TRF does not inhibit, or 
preferably improves, physical performance. Additional studies should also focus on measures of 
CRF. 
Animal Trials 
 To the author’s knowledge, only one animal study has included any physical performance 
measure following TRF. Gill et al. indicated that 5 weeks of 12-hour TRF in wild type Drosophila 
significantly improved ability to fly, as measured by flight index (93). However, the study failed 
to specify how or when flight performance was measured. Additionally, the researchers did not 
mention the specifics of the flight index that was used. Because of the lack of detail provided in 
the paper of Gill and coworkers and the fact that  no other studies are available in this area, more 
studies are needed to better understand the potential influence of TRF on physical performance in 
animals.  
TRF and Body Composition  
Human Trials 
 To the author’s knowledge, three studies have examined the relationship between TRF and 
body composition. One study reported moderately favorable body composition outcomes, while 
the other two studies reported extremely favorable body composition outcomes. The two studies 
described above in the TRF section reported measures of body composition in addition to the 
aforementioned measures of muscular performance. Tinsley et al. measured body composition via 
DXA (51). No significant differences existed relative to baseline or between groups for total body 
mass, FFM, or FM. However, the study did state that, though the difference was not significant, 
FFM increased in the control group (+2.3 kg FFM) and decreased in the TRF group (-0.2 kg FFM). 




most likely be attributed to the training status of the participants (i.e. untrained) and the caloric 
demand associated with hypertrophy during the onset of training.  
Alternatively, Moro and colleagues reported very promising results. They used DXA to 
measure body composition at baseline and post-intervention (53). The study indicated that 
participants in the TRF group (10.90 ± 3.51 kg at baseline versus 9.28 ± 2.47 kg post-intervention) 
lost significantly more FM compared to the control group (11.36 ± 4.5 kg at baseline versus 11.05 
± 4.27 kg post-intervention). The TRF group also experienced greater reductions in %FM relative 
to the control group (−16.4 % FM in TRF vs −2.8 % in control). However, despite  losing 
significantly more FM than individuals in the control group, individuals in the TRF group (73.08 
± 3.88 kg at baseline versus 73.72 ± 4.27 kg post-intervention) did not exhibit significantly 
different levels of FFM post-intervention when compared to baseline or the control group (73.93 
± 3.9 kg at baseline versus 74.41 ± 3.59 kg post-intervention). Additionally, measurements of mid-
arm circumference and mid-thigh circumference did not differ between groups or from baseline 
for either condition.  
 A third study examined the effects of an 8-week 20/4 (20-hour feeding period, 4-hour 
fasting period) TRF intervention on body composition in normal-weight, middle-aged adults (n = 
15) (52). All meals were provided by the lab staff, and caloric intake did not differ between the 
control condition (3 meals daily) and the intervention condition (all food consumed between 
5:00pm – 9:00pm). Body composition was assessed via BIA at baseline and post-intervention. 
Favorable changes in body composition were exhibited post-intervention. Relative to the control 
condition, the TRF condition exhibited significantly greater weight loss (1.4 kg) and reduction of 
FM (2.1 kg). No differences were observed between-groups for FFM. Additionally, none of the 




 No studies have measured body composition in overweight or obese individuals following 
TRF. However, the evidence discussed in this section shows that similar individuals can achieve 
loss of FM and retention of FFM through TRF. Further studies should apply these findings to an 
obese sample to ascertain if similar alterations in body composition are attainable through TRF.  
Animal Trials 
A majority of animal trials that have reported body composition have indicated that TRF 
has a major impact on body mass and FM. Studies show that mice fed during the dark phase (active 
phase) display significantly lower total body mass and lower total FM and %FM when compared 
with mice fed ad libitum or during the light (inactive) phase (99, 108, 117, 118). Notably, this 
reduction appears to occur independent of diet composition. Studies have demonstrated that mice 
fed a high fat diet during the dark phase display lower %FM relative to controls (107, 108). No 
studies have described alterations in FFM or %FFM following TRF. More research is needed to 
determine how TRF affects FFM in animals.  
Alternate Day Fasting 
 Alternate day fasting (ADF) is a type of IF protocol that has received increased attention 
from members of the scientific community over the past decade. ADF regimes consist of 
alternating “feed” and “fast” days, often grouped in 14-day cycles. For example, ADF protocols 
should be arranged such that individuals experience 7 fast days and 7 feed days over a given 14-
day period. Feed days typically consist of ad libitum caloric consumption (27), although at least 
one study has implemented a caloric limit on feed days (60). Fast days involve either total or severe 
caloric restriction. ADF interventions that eliminate caloric intake for the entire 24-hour period are 
considered traditional ADFs (54, 59). Traditional ADFs may permit consumption of calorie free 




interventions that allow for consumption of a small meal on fast days are termed modified ADFs. 
(56, 57). Modified ADFs typically permit consumption of 1 small meal on fast days in an effort to 
depress feelings of hunger on fast days and, ultimately, attrition rates. These meals typically consist 
of 25-30% of normal daily caloric consumption and are typically consumed in the early afternoon 
(55, 94), though evidence has suggested that meal timing on fast days does not impact outcomes 
(58). 
Alternate Day Fasting: Overview of Current Literature 
Human Trials 
 The benefits of ADF in humans have been well-documented. Thus far, studies have 
primarily focused on ADF in obese populations (56), although some trials have included normal-
weight and over-weight participants (54, 56). Many of these publications have utilized a modified 
ADF intervention (55, 58, 60, 119, 120), while relatively few studies have implemented a 
traditional ADF in humans (54, 59). Additionally, although most studies have utilized short-term 
(2-12 week) ADF interventions, the results have been encouraging.  
Generally, human trials have reported improved health-related outcomes following ADF. 
Studies have repeatedly shown that ADF is effective for inducing weight loss in both obese (55, 
57-60, 121, 122) and non-obese individuals (54-56), while resulting in favorable changes in body 
composition (these variables will be discussed in further detail below) (57, 59). Additionally, ADF 
has been associated with improved measures of cardio-metabolic health, including decreased 
cholesterol (56, 59, 98), decreased LDL levels (56, 59, 98), decreased triglyceride levels (56, 59, 
98), and decreased blood pressure (56, 57, 60). These cardiovascular-health-related benefits of 




one study has also shown that markers of inflammation and oxidative stress may be improved 
following ADF in obese individuals with asthma (122). 
 Some null or negative findings have been associated with ADF. One study failed to report 
reductions in total body mass, likely due to the short duration of the 2-week intervention used (96). 
Another study has indicated that short-term ADF can lead to unfavorable reductions in HDL levels 
(59). Still others have indicated that ADF results in the loss of FFM (54, 59). Interestingly, all of 
these undesirable outcomes have been reported following traditional ADF. Potentially, the total 
elimination of any caloric intake on fast days of a traditional ADF leads to the development of 
these adverse outcomes. Indeed, Heilbronn et al. address this notion in the discussion section of 
their paper, hypothesizing that a modified ADF that allows for 10-20% of caloric needs on fast 
days may lead to better outcomes (54). Thus, it is recommended that individuals undergo a 
modified ADF for a period of at least 3 weeks for best clinical results.  
Animal Trials 
 ADF interventions conducted in animal models have yielded positive results. Similar to 
simple CR, ADF has been reported to protect against the development of several severe negative 
health outcomes, such as diabetes, cancers, heart disease, and neurodegeneration (123). ADF has 
also been associated with significant cardio-protection (124). Studies have indicated that ADF 
favorably alters measures of cardiovascular health by lowing heart rate, blood pressure, blood 
insulin, and blood glucose (125, 126). Moreover, ADF has been shown to induce weight loss and 
prevent weight gain (125, 127-129), as well as decrease visceral fat mass (129, 130). Indeed, 
weight loss appears to be achievable through ADF despite the consumption of a high fat diet (131). 
Ultimately, these protective effects of ADF may result in increased longevity (132, 133). 




 To the author’s knowledge, no studies have reported any measure of physical fitness or 
physical performance with respect to ADF in humans or animals. However, because high FM and 
low FFM are associated with decreased physical fitness and performance (7, 8), it is expected that 
ADF would improve physical fitness and performance simply by improving body composition in 
overweight and obese individuals and animals. 
ADF and Body Composition  
Human Trials  
 Relative to simple CR, ADF seems to have the potential to induce favorable changes in 
body composition. Similar to simple CR, ADF has been shown to result in significant reductions 
in FM (54-59), visceral FM (58), and waist circumference (57, 60). However, whereas simple CR 
often results in loss of FFM, modified ADFs have demonstrated the ability to maintain FFM during 
weight loss. Three out of four studies that have measured FFM have reported no significant 
reductions in FFM relative to baseline (55, 57) or relative to a control group (56) following the 
completion of a modified ADF protocol.  
 It should be noted that while individuals appear to retain FFM relatively well during 
modified ADF, traditional ADF may result in significant reductions in FFM. The only two 
traditional ADF trials in humans have reported significant decreases in FFM following 
interventions of 3 (54) and 8 weeks, respectively (59). For this reason, modified ADFs are 
recommended for optimizing loss of FM and retention of FFM during ADF.  
Animal Trials  
Interestingly, though many animal studies have reported ADF-induced weight loss, few 
studies have investigated body composition following ADF, and these results are conflicting. Two 




significant difference in inguinal adipose mass or epididymal adipose mass following a 4-week 
traditional ADF (32). A subsequent study also failed to report significant differences in fat mass 
between control and ADF groups after 4 weeks of ADF (130). Only one study, conducted by 
Dorighello et al., has reported successful reductions in total fat mass. This study indicated that a 
12-week traditional ADF was successful in reducing epididymal fat pad mass in wild-type mice 
(134). No studies have reported measures of total FFM.  
While the literature has failed to support unequivocally the claim that ADF reduces fat 
mass in animals, it should be noted that preliminary evidence has suggested that ADF can alter the 
size and distribution of adipose cells in clinically meaningful ways. ADF has been shown to 
favorably alter adipose tissue distribution by decreasing visceral fat mass and increasing 
subcutaneous fat mass (130). Because visceral obesity has been linked to increased incidence of 
insulin resistance, cardiovascular events and premature death, decreases in visceral fat mass are a 
significant finding (130). Additionally, another study has indicated that ADF results in decreased 
inguinal adipose cell size (32). This finding is important because large adipose cells have been 
reported to increase the risk of developing chronic disease (130). So, while the evidence does not 
yet fully support the notion that ADF leads to decreased total FM in animals, studies do suggest 
that ADF favorably alters the composition and distribution of FM, a worthwhile outcome.  
Dietary Restriction 
 Dietary restriction (DR) is a dietary modification in which an individual reduces or 
eliminates the consumption of one or more specific dietary components (28).  DR commonly 
involves the reduction of a specific macronutrient (carbohydrates, lipids, or proteins), but other 
dietary components may be the subject of DR. One such example is methionine (an essential amino 




animal models (135). Though the primary goal of DR may not be calorie restriction, it typically 
results in reduced caloric intake by default. The Daniel Fast is an example of a DR model that 
typically leads to decrease in caloric consumption, relative to normal ad libitum calorie intake. 
 The Daniel Fast (DF) is a religious fast, derived from the Bible (29). Typically, individuals 
partake in the DF for a 21-day period, as described in the book of Daniel. It is a strict vegan diet 
that inherently leads to reduced caloric intake. Individuals participating in a DF may consume 
fruits, vegetables, whole grains, nuts, legumes, seeds, and healthy oils (such as olive oil) ad libitum. 
Products that contain additives or preservatives, as well as coffee and alcohol, are prohibited. 
Because the DF involves ad libitum intake of the permitted foods, individuals may find it an easier 
model to follow than other caloric restriction models. 
Daniel Fast: Overview of Current Literature 
Human Trials 
Several studies have shown the Daniel Fast, followed for as few as 21 days, to improve 
markers of health. All have been conducted at The University of Memphis. In the first such study 
conducted, Bloomer and colleagues implemented a 21-day DF in 43 human participants (13 men; 
30 women; 35 ± 1 yrs; range: 20-62 yrs) to assess its effects on metabolic and cardiovascular risk 
factors (29). Participants were not excluded based on body mass. Thus, individuals with a variety 
of BMIs enrolled in the study: 21 participants were considered to have a “normal” BMI (BMI < 
25 kg∙m-2); 9 participants were considered overweight (BMI 25-29.9 kg∙m-2); and 13 participants 
were considered obese (BMI > 30 kg∙m-2Participants were generally considered to be healthy 
individuals. Thirty-four of 43 participants were considered exercise trained (participate in 3 hours 
of anaerobic and aerobic exercise per week). A pretest was conducted for all tested variables before 




metabolic and cardiovascular markers of health had improved following the 21-day fast.  Amongst 
other variables, total cholesterol (171.07 ± 4.57 vs. 138.69 ± 4.39 mg·dL-1), systolic blood pressure 
(SBP; 114.65 ± 2.34 vs. 105.93 ± 2.12 mmHg), and diastolic blood pressure (DBP; 72.23 ± 1.59 
vs. 67.00 ± 1.43 mmHg) were significantly lowered when compared to baseline values (p < .05). 
Additionally, insulin blood-concentrations and HOMA-IR scores were lowered (p > .05) by 
clinically meaningful values. Moreover, total caloric intake was significantly reduced during the 
intervention period when compared to baseline (2185 ± 94 vs. 1722 ± 85 kcals). The only noted 
downside of the DF was a significant decrease in HDL-C. Thus, Bloomer et al. concluded that a 
21-day DF can result in key metabolic changes that may improve overall health.  
A year later, a subsequent study was published on the same data set which assessed 
antioxidant status and markers of oxidative stress following a 21-day DF (136). Results showed 
that a 21-day DF positively effects antioxidant status and markers of oxidative stress. 
Concentrations of certain variables increased significantly (p < .05) post-intervention, including 
Nitrate/Nitrite (NOx) and Trolox Equivalent Antioxidant Capacity (TEAC). Markers of oxidative 
stress were reduced, post-intervention. Malondialdehyde (MDA) levels were significantly lowered 
(p = .004) by 15%. H2O2 levels were also meaningfully lowered (p = .074) by 14%. Together, 
these data indicate that a 21-day DF can lower levels of oxidative stress while raising levels of 
antioxidants.  
Subsequent studies have validated the majority of these results. In 2012, Bloomer et al. 
conducted a 21-day DF on 22 participants to examine post-prandial oxidative stress. Ten men and 
12 women (aged 35 ± 3 years) completed the study (62). Participants had a wide variety of BMIs 
(13 normal, 4 overweight, and 5 obese). Bloomer and colleagues noted no significant decrease in 




were lowered post-intervention. NOx increased following the DF (TEAC was not significantly 
higher). Total caloric intake was lowered by 16% during the DF.  
A modified DF has also been shown to produce meaningful health benefits (61, 63). A 
modified DF is inclusive of dietary components that are excluded in a traditional DF. In a study 
published in 2012, Trepanowski and colleagues instructed participants in the experimental group 
to consume krill oil capsules (2 g/day in 2 daily dosages of 1 g) daily in an effort to maintain HDL-
C levels (61). While HDL-C levels were not significantly different between the control and 
experimental groups, the litany of health benefits reported in the original study conducted by 
Bloomer et al. in 2010 were observed. Similarly, Alleman and colleagues reported a significant 
decrease in HDL-C following a 21-day DF modified to include one serving of lean meat (3 oz.) 
and dairy (8 oz. skim milk) per day (63).  
Animal Trials 
 To date, two studies have implemented a DF intervention in an animal model. Bloomer et 
al. utilized a 3-month DF intervention in male Long-Evans rats (n=60) to determine the effects of 
the DF on physical performance, body composition, blood lipids, oxidative stress and 
inflammation (Bloomer, unpublished). Following a 2-week acclimation period, animals were 
assigned to an exercise group and a diet group. Two exercise groups existed, with animals either 
being assigned to the exercise-trained group (E), which exercised 3 times weekly on a treadmill, 
or the sedentary group, which was only permitted normal daily activity. Two diet groups were 
used, with animals either assigned to an ad libitum WD group or an ad libitum DF group. At the 
conclusion of the study, DF rats displayed relatively lower body mass, cholesterol, triglycerides, 




displayed greater physical performance increases, relative to the WD+E group. Markers of 
inflammation did not differ between groups. 
 In a separate publication, Daniels et al. detailed how the intervention described above 
affected the rats’ viscera, particularly the small intestine. Daniels et al. reported several key 
findings. Following the 13-week intervention, WD rats had heavier livers than DF rats (25.9 ± 2.0 
kg versus 17.1 ± 0.6 kg). The intestines of the WD rats were shorter when compared to the DF 
rats’ intestines. The weight of the WD rats’ intestines represented a smaller percentage of total 
body weight (g∙kg-1 body weight) than the intestines of the DF mice. The WD rats intestines 
displayed shallower crypts and narrower villi, compared to the DF rats’ intestines. These results 
are likely the result of the low fat, high fiber composition of the DF diet and indicate that the small 
intestines of DF rats adapted to become more absorptive per kg of body weight compared to the 
WD rats’ small intestines.  
Daniel Fast and Physical Performance  
Human Trials 
 No human trials have tested physical fitness following DF. However, many subjects have 
commented that they “feel” better physically when following the DF eating plan. Of course, 
quantitative data are needed to confirm improvements in performance.  
Animal Trials 
To date, only one study has examined the relationship of the DF and physical fitness. This 
study utilized a 3-month DF intervention in male Long-Evans rats to determine the effects of the 
DF on physical performance (Bloomer, unpublished). Baseline cardiorespiratory capacity was 
measured for all animals as run time to exhaustion. Following the conclusion 3-month intervention, 




exercise groups, relative to baseline. However, exercise capacity increased significantly more 
(99% increase) in the DF + E when compared to the WD + E group (51% increase), indicating that 
the DF increased exercise gains independent of body mass.  
Daniel Fast and Body Composition 
Human Trials 
To date, the DF has not resulted in consistent and favorable body composition alterations 
in humans but has resulted in a mean weight loss of approximately 4-6 pounds over a three week 
intervention period. Only one study has displayed significant reductions in total body mass and/or 
FM (61). Following a 21-day DF intervention with krill oil supplementation, body weight (74.1 ± 
2.4 versus 71.5 ± 2.3 kg), fat mass (21.9 ± 1.5 versus 20.8 ± 1.5 kg), and fat-free mass (52.2 ± 2.0 
versus 50.8 ± 1.9) all decreased significantly, relative to baseline. However, other studies, using 
either a traditional DF or a modified DF (inclusion of one serving of meat and one serving of dairy 
per day), have not reported significant improvements in any measure of body composition (29, 62, 
63).  Two traditional DF studies have reported measures of body composition. The first traditional 
DF study indicated that total body mass (77.5 ± 3.0 versus 74.7 ± 2.7 kg), %FM (30.2 ± 1.6 versus 
29.9 ± 1.6%), %FFM (53.8 ± 2.0 versus 52.1 ± 1.9%), and waist circumference (92.2 ± 2.0 versus 
90.4 ± 2.0 cm) remained unchanged at the conclusion of the 21-day intervention (29). Similarly, 
the second traditional DF study reported that body mass (77.8 ± 3.8 versus 75.1 ± 3.5 kg), FM 
(21.1 ± 2.2  versus 19.9 ± 2.1 kg), %FM (26.7 ± 2.3 versus 26.1 ± 2.1%), FFM (56.7 ± 2.8 versus 
55.2 ± 2.7 kg), and waist circumference (88.7 ± 2.9 versus 87.5 ± 2.9 cm) remained unchanged at 
the conclusion of the 21-day intervention (62) . A DF modified to include meat and dairy also 
reported no changes in body composition following 21 days of DF, including no changes in total 




group (74.5 ± 6.1 versus 72.4 ± 5.7 kg); no changes in %FM in the traditional DF group (35.7 ± 
2.4 versus 35.5 ± 2.5%) or in the modified DF group (33.8 ± 3.5 versus 33.4 ± 3.6%); and no 
changes in %FFM in the traditional DF or the modified DF group (63). The lack of findings of 
statistically significant weight loss in these studies is likely due to the short duration of the 
intervention (21 days) and the variability in subjects’ response. 
 
Animal Trials 
 The animal trial discussed above in Daniel Fast and Physical Fitness also reported 
measures of body composition. The data indicated that DF is effective in preventing weight gain 
in rats, relative to ad libitum feeding (Bloomer, unpublished). Rats in the WD group (571.1 ± 14.7 
kg) weighed significantly more post-intervention than all other groups (516.8 ± 10.7 kg WD + E; 
478.7 ± 11.3 kg DF + E; 496.8 ± 13.5 kg DF). Additionally, rats in the DF groups weighed 
significantly less than rats in the WD groups (data not given). Bloomer et al. also reported a group 
effect for %FM. Both DF groups (20.3 ± 1.3% DF + E; 24.6 ± 1.4% DF) displayed lower %FM 
than both WD groups (30.6 ± 1.3% WD + E; 33.5 ± 1.0% WD). Furthermore, no significant 
between-group differences were noted for FFM (366.0 ± 9.2 kg WD + E; 386.8 ± 6.7 kg WD; 
391.4 ± 8.8 kg DF +E; 376.5 ± 7.8 kg DF), indicating that the DF may be effective in attenuating 
FFM loss in animals.  
Conclusion 
 Obesity is a multifactorial disease that presents myriad problems, both in the United States 
and worldwide. It is associated with increased risk of chronic, and potentially fatal, disease, such 
as cardiovascular disease, heart attack, and suddent death (14). Additionally, obesity places a major 




the rise of obesity worldwide is a primary goal of many healthcare organizations, such as the World 
Health Organization. This goal may be achieved through dietary modification.  
 Though more research is needed, three novel dietary interventions – time-restricted 
feeding, alternate day fasting, and the Daniel fast – appear able to successfully induce weight loss, 
while simultaneously generating additional positive health outcomes. However, each one of these 
dietary modifications currently displays unique benefits. TRF causes the most favorable changes 
in body composition. While studies have linked DF and ADF to insignificant or unfavorable 
alterations in body composition, studies generally show that TRF leads to significant reductions in 
FM (52, 53, 99) without reducing FFM (52, 53). Additionally, because TRF permits the daily 
consumption of a high-fat diet, it has an added psychological benefit, relative to ADF (which 
severely restricts caloric intake every other day) and DF (which eliminates processed foods). 
Conversely, ADF is the only dietary modification out of the three that has been shown to 
consistently reduce total body mass in a significant manner. Varady et al. and others have 
repeatedly demonstrated that ADF results in significant reductions of total body mass (54-56, 59). 
TRF and DF have yet to consistently demonstrate large improvements in weight, though TRF has 
not been utilized in an obese sample, and DF studies have yet to span longer than 3 weeks in 
humans. DF appears to be the most comprehensive dietary modification, compared to TRF and 
ADF. DF studies have shown improvements in virtually every health-related factor, despite short-
term interventions (29, 61, 63, 136). Additionally, DF is the only dietary modification that has 
been shown to increase physical performance (Bloomer, unpublished). 
 Despite the promising results of the literature detailed above, much still needs to be learned 
about these dietary modifications. Little literature has been published on DF and TRF, and few of 




indicators of overall health. Moreover, no studies have implemented TRF, ADF, and DF in the 
same study to compare outcomes of each dietary modification. Thus, a single study comparing 
TRF, ADF, and DF is needed to determine the relative effectiveness of these dietary modifications 
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Date submitted to Attending Veterinarian for pre-review:  
 
IACUC Protocol #                                               Date Submitted to IACUC  
 
Dates Protocol will be in effect:                              from                                  to  
(not to exceed three years including two yearly renewals) 
 
Is this protocol related to an external grant or contract application?                Yes           No   
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University account for Animal Care Facility per diem charge:   
 













University account for Animal Care Facility per diem charge:   
 
Project Title: (If project relates to a grant or contract application, give that title; if multiple 
protocols relate to one grant, give unique titles for each protocol; if the project is related to a 
class, give the course name and number): 
 
Impact of dietary and caloric restriction models on metabolic health and physical function in 
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Campus phone:                                                     Emergency phone:   
 
Attending Veterinarian:    
 
Phone:                                                                   Emergency phone:  
211700 
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List all individuals that will handle animals using this protocol, their affiliation, and their level of 





Marie van der Merwe, PhD (Molecular Pharmacology), Postdoctoral Fellowship (Bone 
Marrow Transplantation): More than 10 years of experience using mice as a research 
model. 
 
Richard Bloomer, PhD: 2 years of prior experience using rodents in research. 
 
Melissa Puppa, PhD: 8+ years of experience working with mice including breeding, 
exercise training/testing, injections, surgery, dietary interventions, gavage, GTT, 
electroporation, blood collection, and dissection/necropsy. 
Matt Butawan: 2 years of rodent handling experience. 
Harold Lee: 1 year of rodent handling experience, including exercise testing (treadmill 
running). 
Sunita Sharma: 6 months animal handling experience; has been to Laboratory Animal 
Training. 
Nick Smith: No experience with animals, but has been to Laboratory Animal Training; 
training will be provided during experiment. 
Jade Caldwell: No experience with animals, but has been to Laboratory Animal 
Training; training will be provided during experiment. 
Kyle Truska: No experience with animals and will attend Laboratory Animal Training; 








If additional personnel become involved in handling animals used in this protocol, it is the 
responsibility of the principal investigator to notify the Animal Care Facility in writing 
before they start. 
Has the investigator/instructor and all personnel listed above received the appropriate 
vaccinations (tetanus, rabies)?                                   Yes           No          Not Applicable   
Will be done by the time the study is initiated.  
Is it necessary for personnel listed on this protocol to be tested for TB? 
                                                                                   Yes           No   
If you have questions about the kind of vaccination or about TB, call the Animal Care 
Facility at 678 2359. 
All U of M personnel involved in this protocol must complete the animal care and use 
training program before animals can be procured or before experiments/teaching or 
demonstration.   In submitting this protocol, I, as Principal Investigator/Instructor accept 
the responsibility for compliance with this requirement. 
In addition, the Principal Investigator/Instructor must be willing to provide appropriate 
supervision for all persons working on this protocol.  In the case of a class, the Instructor 
must be responsible for training any students in classes involved prior to using animals. 
 
 
II.  Project Description 




Obesity has become an epidemic in the Western world, largely due to poor dietary 
habits. Multiple dietary programs have been studied in recent years, showing promise 
with regards to weight loss and improvement in multiple health related outcomes, 
including glucose control, inflammation, and oxidative stress. More recently, a great 
deal of attention has been placed on the microbiome and the influence of dietary intake 
on this very important component of overall health. What is unknown is the degree of 
improvement noted when following each of the popular dietary regimens as compared 
to simple caloric restriction. That is, are certain protocols more beneficial than others 
and if so, in regards to which specific outcome(s)? Much debate centers on these 
questions and no study has sought to make direct comparisons between the well-
investigated protocols. 
 
In fact, most dietary protocols have simply been compared to a typical high fat 
Western diet. Very few comparison studies have been conducted inclusive of the four 
most common dietary approaches: Caloric Restriction (CR), Dietary Restriction (DR), 
Time Restricted Feeding (TRF), and Alternate Day Fasting (ADF). The goal of the 
present study is to directly compare the above four dietary plans to a Western Diet, 
with regards to body mass/body fat, physical performance, insulin sensitivity, 
inflammation, oxidative stress, and the microbiome. A diet of standard rodent chow 
will be used as a control. Outcome measures will be determined after 8 weeks of 
assignment to the dietary programs, with a total of 56 animals assigned to one of 7 diet 




4 week old C57BL/6 male mice will be entrained under a 12h light: 12h dark schedule 
for two weeks with standard rodent chow available ad libitum.  During the entrainment 
period, mice will begin the reverse light-dark schedule, with lights off between the 
hours of 7am-7pm. This will be done so that the feeding time will be during the active 
phase (“light off” phase) of the mice. Mice will be housed in Life Sciences in an area 
that is currently used for studies of the circadian rhythm and therefore the light is well-
regulated. After two weeks of entrainment, all but 8 mice will be switched to a Western 
diet for four weeks, consisting of 45% fat with lard as the fat source. This additional 
four week period of ad libitum feeding should allow for significant weight gain. Eight 
mice will continue following a standard chow diet during this 4-week period and serve 
as a low-fat control diet group. They will maintain this same diet throughout the entire 
study period. Following the 4-week period, the mice fed the Western diet will be 
divided into 6 additional groups: Western, CR, DR, TRF, ADF, and chow.  
 
A MRI for the determination of body mass/fat and treadmill run to exhaustion will 
occur at baseline (prior to starting the specific diet plan) and following eight weeks on 
the specific diet assignment. Before and after the 4-week period of Western diet 
feeding and at the end of the intervention period, a glucose tolerance test will be 
performed. Mice will be fasted for 7 hours and glucose levels measured in 10 ul of 
blood collected via the tail vein.  Glucose will be administered intraperitoneally and 
blood glucose measured every 30 minutes for 90 minutes from 10 ul of blood collected 
from the tail vein. At the end of the dietary intervention, prior to sacrifice, blood will 




oxidative stress markers, cytokines, immune cell populations, and other variables. All 
mice will be sacrificed by CO2 inhalation. Tissues will be harvested immediately. This 
form of euthanasia does not affect the outcome measures as determined by our 
previous studies. Organs to be harvested are liver, spleen, intestine, lymph nodes, 
adipose tissue, skeletal muscle, and heart. 
 
B. Describe IN DETAIL the procedures you will follow. Include accompanying 
documentation and reference to previously published work in the box below.  Provide a complete 
bibliographic citation and describe any variations from the published technique.  The 
bibliography may be included in the box below or appended to this protocol. 
Mice: 56, 4 week old C57BL/6 male mice will be purchased from Envigo or another 
vendor. After arrival, mice will be co-housed (as done in reference 1) at the animal 
facility on the University of Memphis campus. 
After arrival at the University of Memphis, mice will be entrained under a 12h light: 
12h dark schedule for two weeks with standard rodent chow available ad libitum.  
During the entrainment period, the light-dark cycle will be reversed with lights off 
between the hours of 7am-7pm. This will be done so that the feeding time will be 
during the active phase (“light off” phase) of the mice. Mice will be housed in Life 
Sciences in an area that is currently used for studies of the circadian rhythm and 
therefore the light is well-regulated. After two weeks of entrainment, all but 8 mice 
will be switched to a Western diet, consisting of 45% lard and 41% carbohydrate (20% 
sucrose, 9% corn starch, and 12% Maltodextrin).  This additional four week period of 




mice will be divided into 6 additional groups and will consume their respective diets 
for an additional 8 weeks.   
Group 1 will have access to a standard rodent chow ad libitum, 24 hours per day.  
Group 2 will have access to a purified, high-fiber, vegan-based diet ad libitum, 24 
hours per day. We have used this same customized diet in past studies and it results in 
normal weight/muscle mass gain, while minimizing fat accumulation. This will be the 
DR arm of the trial.  
Group 3 will have access to the Western diet ad libitum, 24 hours per day.  
Group 4 will have ad libitum access to the Western diet for 6 hours at the beginning of 
their active phase (7am-1pm). This will be the TRF arm of the trial. We have used this 
exact feeding protocol in a recent investigation of mice. No negative health 
consequences were observed using this protocol. 
Group 5 will be on the alternate day fasting (ADF) protocol and have ad libitum access 
to the Western diet every other day. That is, on day 1 they will have unrestricted access 
to food during the entire 24 hour period. On day 2 they will receive no food. On day 3, 
they will have unrestricted access to food, and so on.  This same protocol has been 
used in mice in several studies without incident. Please see references 2-10. It should 
be noted that if the ADF protocol leads to significant weight loss beyond what would 
be expected for mice following such a plan (≥20% body mass as compared to their 
body mass at the start of the intervention period [after 4 weeks of following the ad 
libitum Wester diet]) and/or mice show signs of stress or  impaired health (e.g., scruffy 
coat, hunched posture, excessively aggressive behavior), the attending veterinarian will 




instead of receiving no food on the fasting days, mice will receive 20% of the daily 
calories in the form of the Western diet during a one hour period at the mid-point of the 
animals’ active phase (12-1pm).  
It should be noted that animals in all groups will be monitored daily for signs of stress 
and impaired health, with particular attention given to animals in the ADF group. 
Monitoring body weight three times weekly should be more than adequate and should 
not cause undue stress to the animals due to frequency of handling. 
Group 6 will receive 80% of ad libitum intake of the Western diet as determined during 
the prior 4 week period. This will be the CR arm of the trial. Multiple rodent studies 
have reduced caloric intake by 20-40% without incident. See references 5 and 11-17. 
Al mice will be monitored daily for sign of malnutrition and stress.  
The diets will be purchased from Research Diets, which has experience in producing 
the Western diet and purified vegan diets for rodent studies. The mice will remain on 
their particular diets for eight weeks and then post-testing will begin. Mice will 
continue on their diets until all testing is completed (~ end of week 9). Water will be 
provided ad libitum throughout the study period. The amount of food consumed will be 
measured daily and the weights of the mice will be taken three times per week at the 
same time of day. There will be a total of 56 mice assigned in this study. 
There will be two mice housed per cage. From our previous studies we know that 
genetically similar mice eat basically a constant volume of food. We can therefore pair-
house the mice and determine an average amount of food consumed. Previous studies 
have used a similar set up where 3-5 mice were co-housed (Hatori et al.). If there are 




food, those specific mice will be separated into individual cages. Food will be weighed 
daily. Mice will be weighed 3 times per week at the same time of day.  A glucose 
tolerance test (GTT) will be performed at the beginning of the experiment (when mice 
are put on their respective diets) and following 8 weeks after the start of the dietary 
intervention. The final GTT will be performed 48h prior to euthanasia. For the glucose 
tolerance test, mice will be fasted for a minimum of 7 hours and blood glucose levels 
determined by blood from tail vein. Mice will be given a 1g glucose/kg body weight 
intraperitoneally and blood (10ul) collected every 30 minutes for 90 minutes to 
measure glucose levels. For blood collection, mice will be placed on a flat surface and 
restraint by gently holding onto the tail without pulling. The tip of the tail will be 
snipped – 1mm region. This part of the tail has little nerve innervation and does not 
cause the animal any distress. By “milking” the tail, blood can be collected at multiple 
time points without having to cut again.  Isoflurane cannot be used as it increases blood 












In addition to the GTT, prior to commencing the specific diet plans (after the initial 4 week 
period on the Western diet), animals will undergo a MRI for determination of body mass/body 
fat. Body composition will be determined using an EchoMRI™ 1100. The MRI is housed in 
room 115 in Life Sciences, the same location that our mice are housed in. For scanning, animal 
are placed with cylindrical tube holders and movement restricted to the bottom 7.5 cm as stated 
in the instrument manual and the study by Jones et al. (Validation of quantitative resonance for 
the determination of body composition of mice. Int. J Body Compos Res. 2009; 7(2):68-72). The 
animals are scanned without anesthesia, sedation or restraint and are free to move within the 
holder. The smallest possible holder is used to limit the movement of the mouse (without 
constraining them) in order to reduce measurement errors induced by motion. Scanning time is 
approximately 40 seconds.  There is no prior training required for the animal. We have prior 
experience using this system in mice. 
 
Finally, animals will undergo a treadmill run test to exhaustion using a motorized 
treadmill without incline. Specifically, mice will be acclimated to the treadmill prior to 
testing. Run to fatigue test will be performed twice in the mice; once prior to starting 
the 8 week intervention and at the end of the 8 week intervention. Animals will run 
using a 5% grade at 20m/min for 30 min and 25m/min for the remaining time until they 
reach exhaustion. A warm up phase will be provided for 15min (5min at 5m/min, 5min 
at 10m/min, 5min at 15m/min). Fatigue will be defined as the time at which mice are 
no longer able or willing to keep up with the speed of the treadmill despite gentle hand 
prodding for a period of 30 seconds. Very mild electric shock will only be used if mice 




protocols demonstrates that mild shocking is preferable to obtain the best running 
performance. The frequency and amplitude of shock will be as low as possible to 
motivate the animals to remain on the treadmill belt, without causing unnecessary 
distress. We have used small electric shock in prior studies and this is well-accepted in 
rodent running studies. Equipment will be cleaned upon the completion of testing with 
ethanol solution. All urine and feces will be cleaned off of the device and the 
surrounding area.  
After 8-9 weeks of dietary intervention, mice will be euthanized (CO2 inhalation) and 
with cervical dislocation. Tissues will be harvested immediately. This form of 
euthanasia does not affect the outcome measures as determined by our previous 
studies. Organs to be harvested are liver, spleen, intestine, lymph nodes, adipose tissue, 
skeletal muscle, and heart. Immediately prior to euthanasia, blood will be collected via 
the facial vein to measure lipids, glucose, insulin, oxidative stress markers, cytokines, 
immune cell populations, and other variables as needed. Cecum and intestinal contents 
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C. Rationale for Involving Animals and the Appropriateness of Species and Number Used. 
Indicate (here) briefly the short and/or long-term benefits (to humans and/or other animals) of 




of animals to be used.  In addition, state briefly why living animals are required for this study, 
rather than some alternative model. 
The goal of this experiment is to study common feeding patterns in a controlled 
environment over a moderate period of time to determine the cardio-metabolic health 
effects of these dietary plans. Results will provide evidence for or against certain 
models that can then be used by human subjects in an attempt to combat obesity and 
related co-morbidities. We know from our prior work in rodents that the TRF and DR 
models are favorable as compared to a WD. However, we are uncertain as to how CR 
and ADF plans compare. Moreover, we are unaware of studies focused on comparing 
these plans with regards to the microbiome or physical performance. These are 
important areas of interest to scientists and humans who are focused on which dietary 
plan may be “best.” As obesity is becoming more of a problem in the Western world, 
determining which dietary approaches may be best to combat this disease is of great 
importance.  
The C57BL/6 diet induced obesity mouse model has been used previously to study the 
effect of excess weight on various organ systems. As we are interested in the 
interaction between the immune system, oxidative stress, physical performance, and 
other organs, we cannot use isolated cell lines or model organisms such as yeast. 
Additionally, many reagents have been developed for the use of mouse tissues, 
especially antibodies that will be used to identify certain outcome measures. As we are 
focusing on the effect of the different dietary programs on multiple organ systems, it is 




There will be 8 mice per group for a total of 56 mice. This number is the norm for 
similar studies of dietary-induced changes in our health-specific parameters. This 
number should be sufficient to determine statistical significance for the tests planned 






D. Do the procedures described in B above, have the potential to inflict more 
 than momentary pain or distress (this does not include pain caused by  
 injections or other minor procedures)?                                                     Yes           No  
I have considered alternatives to procedures that might cause more than momentary or slight 
pain/distress, and I have not found such alternatives.  As such, I have used one or more of the 
following methods and sources to search for such alternatives: (check below each method used) 
 
 Agricola Data Base  Medline Data Base  CAB Abstracts 
 TOXLINE  BIOSIS  Lab. Animal Sci. Journal 
 Lab. Animals Journal  Lab Animal  Animal Welfare Info Center 
 ATLA (Alternatives to Laboratory Animal Journal)  Quick Biblio. Series 
 Lab Animal Welfare Bibliography (QL55L27311988)  "Benchmarks" 
 "Alternatives to Animal Use in Research, Testing and Education" 
 Current Contents 
 CARL 




List search words for the literature search:   
Daniel Fast, dietary restriction, vegan fasting, fasting, time restricted feeding, intermittent 
fasting, caloric restriction, alternate day fasting, chow, obesity, inflammation, oxidative stress, 




composition, glucose, insulin, blood sugar (words used in isolated and in combination in 
PubMed and Google Scholar).  
 
















III. Animal Use 
A. List all animal species to be used (example below). 






Wistar rats  
45 2 months male 250-350 gm Psychology Bld./422I 
C57Bl/6 mice 56 4 weeks Male 15-20 gm Life Sciences/115 
      
      
      
      
 
        1Individuals using ectotherms need to only approximate numbers. 
  2Individuals using fish or other ectotherms need not answer this question. 







B.  Source of animals 
  Commercial vendor (Source___ Envigo 
Labs_____________________________________________) 
 Bred at The University of Memphis  
 Captured from wild. Identify method of capture:  
 Transferred from another study (IACUC Protocol Number                                                        
 Donated (Source                                                                                                           ) 
 Tennessee Wildlife Resources Agency 
Is the supplier a USDA approved source?                                                         Yes           No  
 
If not, explain why:  
 Animals are already in residence at U of M 
 
C. Will surgery be conducted on animals?                                                    Yes           No  
 
If yes, complete this section: 
 Non Recovery Surgery  Recovery Surgery 
 Multiple Survival Surgery (if the latter is checked, complete section F) 
 
Surgeon(s) (Name/Job/Title/Academic Rank) Location of Surgery (Bldg. & Room #) 
 
 







 Tranquilizing agents be administered?                                                     Yes          No  x                    
If yes, complete this section (example below). 
Species & Sex Agent Dose Route Performed by 
 (Name/Title/Academic Rank) 










     
     
     
     










E. Will euthanasia be carried out?                                              Yes           No                    
If yes, complete this section (example below). 
























Student (Will be trained by 
Dr. Karyl Buddington) 
     
     
     
     
 






F. Will special housing, conditioning, diets or other conditions  





If yes, please explain in box below. 
Mice will be on high fat, chow, or purified diets. Some mice will have restricted access 
to food, either 7am-1pm or every other day. Some mice will have access to only 80% 
of their daily ad libitum intake. 
         
 
G. Will animals be removed from the U of M campus at any time?             Yes           No  
 
 
If yes, please indicate to where and for how long in box below. 
 
H. If they are to be housed for more than 24 hours outside approved facilities at U of M, 







IV. Toxic and Hazardous Substances 
A. Check off any of the following below that will be used in these experiments? 
 Infectious agents (Fill out a, b) 
 Radioisotopes (Fill out a, b, e) 
 Toxic chemicals or carcinogens (Fill out a, b) 
 Recombinant DNA (Fill out a) 
 Experimental drugs (Fill out a) 
 Malignant cells or hybridomas (Fill out a, c) 
 Adjuvants (Fill out a) 
 Controlled substances (Fill out a, d, e) 
 
For each checked off category, answer the questions indicated below: 
a. Identify the substance(s) and completely describe their use, including how will be injected 
or given to the animal(s):  
b. Describe all procedures necessary for personnel and animal safety including  biohazardous 
waste, carcass disposal and cage decontamination: 
c. If transplantable tumors or hybridoma cells are to be injected into the 
 animals, have the tissues/cells been tested for inadvertent contamination  
 by viruses or mycoplasma?                                                                       Yes           No  
 




d. In the box below, provide a complete list of these substances, and if their use is not 
explicitly explained in the materials already provided, explain their use and role in the 
research. 
Provide DEA license # covering the use of these substances:   
To whom (or what entity) is the license issued?   
e. Provide Radioisotope License Number:   









V. Categories of Animal Experimentation Based Upon Level of Manipulation and Pain: 
(check off each category that is applicable to this application) 
 A. Animals will be involved in teaching, research, experiments or tests involving  no 
pain, distress, or use of pain-relieving drugs. 
 B.  Animals  will be subject to mild stress only (e.g., food or water deprivation of less 
than 24 hours for use in behavioral studies such as operant conditioning; physical 
restraint for less than 30 minutes), and will not be subject to surgery, painful stimuli, 
or any of the other conditions described below. Procedures described in this protocol 
have the potential to inflict no more than momentary or slight pain or distress on the 
animal(s)----that is, no pain in excess of that caused by injections or other minor 
procedures such as blood sampling.  
 C. Animals will have minor procedures performed, blood sampling, etc. while 
anesthetized.  
 D. Live animals will be humanely killed without any treatments, manipulations, etc. but 
will be used to obtain tissue, cells, sera, etc.  
 E. Live animals will have significant manipulations, surgery, etc. performed while 
anesthetized. The animals will be humanely killed at experiment termination without 
regaining consciousness.  
 F. Live animals will receive a painful stimulus of short duration without anesthesia 
(behavior experiments with flight or avoidance reactions--e.g., shock/reward) 
resulting in a short-term traumatic response. Other examples in this category are, 
blood sampling, injections of adjuvants, or drugs, etc.  




 G. Live animals will have significant manipulations performed, such as surgery, while 
anesthetized and allowed to recover. Such procedures cause post-anesthetic 
pain/discomfort resulting from the experiment protocol (e.g., chronic catheters. 
surgical wounds, implants) which cause a minimum of pain and/or distress. Also 
included are mild toxic drugs or chemicals, tumor implants (including hybridomas). 
tethered animals, short-termed physically restrained animals (up to 1 hour), 
mother/infant separations.  
 H. Live animals will have significant manipulations or severe discomfort, etc. without 
benefit of anesthesia, analgesics or tranquilizers. Examples to be included in this 
category are: toxicity testing, radiation sickness, irritants, burns, trauma, biologic 
toxins, virulence challenge, prolonged: restrictions of food or water intake, cold 
exposure, physical restraint or drug addiction. All use of paralytic agents (curare-like 
drugs) must be included in this category.  Describe any abnormal environmental 
conditions that may be imposed.  Describe and justify the use of any physical restrain 






VI. Justifications for Category G Studies and Deviations from Standard Techniques 
Describe in the box below any steps to be taken to monitor potential or overt pain and/or distress 
during the course of this study and how such pain or distress will be alleviated. Be as detailed as 
necessary to justify your procedure. 
 
VII. Certifications 
(By submitting this protocol, I am acknowledging that I comply with the certifications 
included in Section VII.)  (check one) 
 Animal Use for Research. I certify that the above statements are true and the protocol 
stands as the original or is essentially the same as found in the grant application or 
program/project. The IACUC will be notified of any changes in the proposed project, or 
personnel, relative to this application, prior to proceeding with any animal experimentation. 
I will not purchase animals nor proceed with animal experimentation until approval by the 
IACUC is granted. 
 Animal Use for Teaching/Demonstration. I certify that the information in this application is 
essentially the same as contained in the course outline and a copy of the laboratory 
exercises using animals is on file in the IACUC office. The IACUC will be notified of any 
changes in the proposed project, or personnel, relative to this application, prior to 
proceeding with any animal experimentation. I will not proceed with animal 
experimentation until approval by the IACUC is granted.  
Estimate the cost of maintaining animals used in this protocol based on current per diem charge 
at University of Memphis. 
 




Please specify cost per unit of time:  
 
Specify anticipated total costs for project duration:   
 
As supervisor of this project it is required that you inform your department chair 
concerning any animal per diem costs related to this project that are to be paid by the 
department.  
 
By submitting this protocol, the Principal Investigator/Course Director indicates that the 
following have been considered: 
 
1. Alternatives to use of animals. 
2. Reduction of pain and stress in animals to the lowest level possible.  
3. The proper needs of the animals with respect to housing and care.  
4. The lowest number of animals used that will give the appropriate experimental results.  
5. Use of the most primitive species that will give the appropriate experimental results.  
6.  Proper training of all personnel in the care and handling of the species used and in the 
procedures called for in this protocol before beginning the experiment/teaching or 
demonstration.  
7. That this protocol is not an unnecessary repeat of results already in the literature or in the 
case of teaching/demonstrations, results that can be demonstrated using models or video 
material.  
 
   $756 (15 weeks) 










Federal Law requires that members of the IACUC be given adequate time to read and review 
protocols including any changes or revisions in them. 
 
Pre-review of protocols by the Attending Veterinarian is required before submission to the 
IACUC.  New protocols or modifications or renewals to protocols must be submitted to the 
IACUC Chair by the 1st business day of the month to be considered for review during that 
month. Incomplete protocols will be returned to the principal investigator.  
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